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Background: Although Zimbabwe has invested in nationwide scale-up of prevention of 
mother to child transmission (PMTCT) services, high HIV-specific under-five mortality 
rates continue to be observed. This study aimed to document the potential reasons for low 
PMTCT uptake by examining factors constraining access to PMTCT services. 
Methods: A cross-sectional facility-based survey based on structured face-to-face 
interviews (n=70)was combined with qualitative research that included two focus group 
discussions with pregnant women and 5 in-depth interviews with providers at antenatal 
care (ANC) clinics in Marondera. 
Results: Financial constraints played a major role in access to care. Sixty-seven percent 
of the women reported financial constraints barred them from utilising ANC services and 
facility-based delivery which are their point of entry to accessing PMTCT services.  
Results showed a statistically significant positive correlation between wealth index and 
ability to pay for services (p<0.001), thus implying access to services is according to 
ability to pay, rather than need for services. Knowledge about PMTCT also played a role 
in women‘s ability to access and exercise PMTCT. Lack of knowledge was related to 
poor communication and inadequate information from health providers. Low quality of 
care including poor provider-patient interactions and generally unclean facilities were 
mentioned as deterrents to the use of services in some facilities. In addition, physical 
access to health facilities was limited in rural areas due to long distances and lack of 
transport.  
Conclusions: Scaling up PMTCT services through integration into ANC can only be 
effective in achieving universal access if barriers faced by prospective clients are 
considered. Results suggest that key improvements would include examining alternative 
financing mechanisms that do not deter patients such as pre-payment mechanisms. In 
addition, while it is important to improve the state of health facilities, it is also necessary 
to find ways in which providers can engage with women in a way that improves the 
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1.1 BACKGROUND  
The main route of transmission of HIV in adults is undeniably through unprotected
sexual interaction, but in children, it remains through mother to child transmission
(MTCT or vertical transmission) (1). The risk of vertical transmission in the absence of
an intervention is estimated to be 20 to 45% (2). To reduce this risk, treatment protocols 
were introduced based on findings from the PACTG 076 trial, which was conducted in
the United States and France (3). Results from this trial showed a significant reduction in
vertical transmission from 25% to 8% after administration of the antiretroviral 
Zidovudine (AZT). Modification of this regimen and additional caesarean section 
birthing and alternative infant feeding options, led to a further decline in the vertical
transmission rate to between 2% and 5% (4). However, this protocol was costly, making
it impracticable in resource-poor settings.
In 1999 and 2003, results from a Ugandan study (HIVNET 012) showed that a single 
dose of Nevirapine (sdNVP) for the mother at labour and the infant after birth was
remarkably successful in reducing vertical transmission, even in the presence of
continued breastfeeding (5 and 6). This approach seemed more feasible and cost-effective
for developing countries (7), and was thus adopted as the main strategy for the prevention
of mother to child transmission of HIV (PMTCT) in resource-poor settings. 
Meanwhile in Zimbabwe, statistics indicated a rise in child mortality with under-five 
mortality rising from 59 to 102 deaths per 1,000 live births between 1985 and 1999 (8). 
This was attributed to various issues but most importantly to the increased cost of 















With the dawn of prophylactic therapy for the unborn child, the treatment protocols for 
PMTCT were quickly adopted by the government of Zimbabwe and the JF Kapnek Trust 
(9). The Trust commenced a pilot programme in the peri-urban suburb of Epworth in 
1999 (9). To initiate the program, they joined forces with the Zimbabwe Ministry of 
Health (MOH) and other local stakeholders. Additional pilot projects were carried out in 
five other sites: three utilising short-course AZT and two utilising sdNVP.  
 
With high success rates from the pilot study, the Trust and the government, with financial 
support from The Elizabeth Glaser Paediatric AIDS Fund (EGPAF), began scaling up the 
PMTCT programme to a national level in 2001 (10). The minimum PMTCT package 
included antenatal care (ANC), voluntary HIV counselling and testing, and sdNVP. 
 
The rapid geographic expansion in the first phase of programme roll-out between 2001 
and May 2003 did not translate into high uptake of the services (10, 11). However, the 
second phase of expansion was commenced soon thereafter covering more ANC facilities 
thus improving physical access to PMTCT services (10, 11). Yet, a decade after PMTCT 
inception in Zimbabwe and despite apparent service availability, utilisation of PMTCT 
services by those in need is still very low and HIV-specific child mortality is still 
unacceptably high (12).  
 
While scaling-up health programmes has been the mainstay of progressive reduction in 
the spread of HIV/AIDS, the fundamental issue lies in the ability to identify and 
eliminate any barriers to accessing these services. Without addressing such issues, the 
challenges of low uptake of PMTCT will continue to be a problem. 
 
This study thus examines the access barriers to PMTCT services in semi-rural and urban 
areas of Marondera in Zimbabwe, and aims to provide guidance on how policies might be 















1.1.1 Overview of Zimbabwe 
Zimbabwe is a land-locked country in southern Africa sharing borders with South Africa, 
Botswana, Zambia and Mozambique. It spans an area of 390,757 km2 with a population 
of 12.6million of whom 63% live in the rural areas (13, 14). 
 
The demographic structure of Zimbabwe is typical of a developing country with children 
below the age of 15 years constituting almost 50% of the total population (13). Black 
ethnic groups comprise 98% of the population, the majority of whom (>80%) are Shona. 
Regarding religion, 75% of Zimbabweans attend Christian churches and less than 1% of 
the population is Muslim. Although Christianity is common, it is often combined with 
enduring traditional beliefs including ancestral worship. 
 
Zimbabwe‘s main source of revenue is derived from the export of primary goods 
including agricultural products such as maize, cotton, tobacco and wheat, and minerals 
such as gold, diamond, iron, platinum and asbestos. However, trade suffered immensely 
due to economic and political instability in the nineties. In turn, coupled to structural 
adjustment programmes, Zimbabwe experienced rising unemployment (14). This 
consequently contributed to rising poverty and illness and low revenue generation for the 
economy (14).  
 
The pattern of diseases in the population has not shown any significant changes within 
the last decade. The major cause of death for all ages remains HIV/AIDS which 
accounted for 67% of deaths in 2002 (15). Other leading causes of death are lower 
respiratory tract infections, tuberculosis, diarrhoeal disease, protein-energy malnutrition 
and war/violence. 
1.1.2 The Marondera district 
Marondera is situated in the Mashonaland east province, 72km east of the capital city 
Harare, and has a population of 154 677 (16). Marondera is a major farming region that 















number of elite private and government schools in the area. The district is also multi-
cultural comprising a variety of ethnic groups. 
There are 3 hospitals, 7 clinics, and 4 rural health centres in Marondera (16). In addition 
to primary preventive and curative services, clinics also offer PMTCT services and 
treatment of HIV-related opportunistic infections. The PMTCT program in Marondera is 
coordinated by a district coordinator under the ministry of health. 
1.2 PROBLEM STATEMENT 
By 2005 in Zimbabwe, the PMTCT programme had only managed to reach 40% of HIV 
positive mothers (11). Of those who were not able to use the service, approximately 40% 
of their children would be infected with HIV and would probably die before the age of 
two years (2). With such a catastrophe looming, it is no surprise that the MOH with the 
help of EGPAF and support from other organisations, continued with plans to improve 
access to PMTCT services by training health workers and equipping facilities with the 
necessary resources for PMTCT services.  
 
However, under-five mortality in Zimbabwe is still too high relative to the target set by 
the Ministry of Health and Child Welfare in line with the millennium development goal 4 
of reducing child mortality ( 86 per 1000 live births versus target 43 per 1000 live births) 
(17). More concerning is the cau e of the high under-five mortality. HIV/AIDS accounts 
for 40% of deaths of children under the age of five in Zimbabwe (15).  Furthermore it is 
estimated that 90% of HIV infection in children under 15 is due to vertical transmission 
(18).  
 
It is indisputable to say there is a problem in the system, a gap between policy 
commitments to reduce MTCT and the success of PMTCT interventions. Therefore this 
study examines what barriers exist to accessing PMTCT services in the public sector and 
how these can be addressed to make the programme more accessible in Zimbabwe. 
1.3 JUSTIFICATION 
Worldwide, MTCT accounts for 20% of HIV transmission making it the second greatest 















highly effective programme in reducing vertical transmission, provided there is adequate 
access to and utilisation of the services. 
However, in Zimbabwe access to PMTCT services has still not been evaluated. Greater 
emphasis has been placed on increasing the number of facilities registered to offer 
PMTCT services and less on the availability of quality services, affordability and 
acceptability of these services, and knowledge and attitudes of the beneficiaries. Whilst 
advances have been made in other countries to assess these issues, it remains a matter of 
local context that defines the necessary steps to be taken. As the Joint Learning Initiative 
on Children and HIV/AIDS (JLICA) pointed out, policy makers need to consider local 
and regional barriers in access to health care in order for future programmes to be well 
integrated into ANC services (20). If the health system of Zimbabwe is to be organized in 
such a way as to increase PMTCT service utilisation, the patient‘s perspective on the 
difficulties of accessing these services needs to be better understood. 
 
This study thus has relevance in that it will identify potential reasons for the small impact 
that PMTCT has had in Zimbabwe and will help policy makers in designing effective 
implementation strategies which will assist the health system in achieving the millennium 
development goal of reducing child mortality.  
1.4   RESEARCH AIM 
Given this background, the aim of this study is to determine reasons for low PMTCT 
uptake by examining factors constraining and facilitating access to PMTCT services. 
1.5 SPECIFIC OBJECTIVES 
1. To assess the availability of PMTCT services  
2. To assess the affordability of PMTCT services 
3. To determine the factors affecting the availability and affordability of PMTCT 
services 
4. To evaluate attitudes of pregnant women towards PMTCT services 
5. To determine women‘s knowledge about PMTCT 
6. To determine the factors associated with women‘s attitude towards and 















7. To provide recommendations on improving access to PMTCT services 
1.6   LITERATURE REVIEW 
The United Nations General Assembly Special Session on AIDS (UNGASS) declaration 
of 2001 (21):  
―By 2005, reduce the proportion of infants infected with HIV by 20 per cent, and by 50 
per cent by 2010, by: ensuring that 80 per cent of pregnant women accessing antenatal 
care have information, counseling and other HIV prevention services available to them.‖  
1.6.1 Introduction 
Child mortality has been rising steadily in Zimbabwe since the mid-eighties (8). This was 
mainly attributed to the direct and indirect impact of the HIV /AIDS epidemic and the 
concomitant rise in poverty levels (17). While the adult HIV prevalence rate in 
Zimbabwe is reported to be declining (22), the question remains as to why the HIV-
specific child mortality rate has continued to be high, years after the PMTCT programme 
was introduced. 
1.6.1.1 What is PMTCT? 
HIV can be transmitted from an HIV positive mother to her child either during 
pregnancy, labour, delivery or breastfeeding (3). PMTCT is thus a set of interventions 
centred on preventing the transmission of the virus from a mother to her child (4). 
Interventions include: 
 Family planning to avoid unplanned pregnancies 
 Voluntary counselling and testing (VCT) 
 Antiretroviral therapy(ART) for mother and infant 
 Safe delivery practices (e.g. caesarean section) 
 Safe infant feeding practices 
 
Table 1 shows the ART options proposed for PMTCT. These are mainly short-course 
ART for the HIV positive mother although sdNVP is also used (23, 24).  
As seen in table 1, the recommended regimens require the pregnant mother to commence 














Table 1 WHO PMTCT Guidelines 2006 & 2010 
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preventing vertical transmission (25). Regimens that propose sdNVP alone carry a higher 
risk of drug resistance. Studies have shown an increased risk in development of resistance 
to future ART if the mother or infant (if infant becomes infected) is exposed to this 
regimen. Nevirapine alone reduces chances of vertical transmission by 47% (26). Short-
course therapies such as AZT at 14-28 weeks in combination with Nevirapine reduce 
transmission by as much as 80%. Hence, where feasible, sdNVP is combined with AZT 















1.6.1.2 Breastfeeding and HIV  
The chances of transmitting HIV from a mother to her child through breastfeeding are 
between 5 and 20% (2). Safer infant feeding practices and concomitant ART during 
breastfeeding are therefore recommended. Mothers with HIV are also advised to replace 
breastfeeding with formula feed whenever it is acceptable, feasible, affordable, 
sustainable and safe (4 and 27).  
 
A lot of controversy surrounds the replacement of breast milk. For instance, breastfeeding 
is known to lower the risk of infant mortality since the child receives protective 
antibodies from the mother which help prevent childhood disease such as diarrhoea, 
pneumonia, neonatal sepsis and acute otitis media (28). However, there is no substantial 
evidence to suggest that an HIV infected mother cannot confer the same immunity to her 
child through breastfeeding (29). It becomes a case of ‗one‘s choice of poison‘ whether to 
breastfeed or not and in most African settings the culturally acceptable way of feeding a 
child remains breastfeeding (30).  
 
Since breastfeeding is the norm, not breastfeeding a child is commonly associated with 
being HIV positive. HIV positive women hence risk being identified as HIV positive and 
fear facing discrimination, should they not practice breastfeeding (30). Another concern 
in developing countries is the availability of safe water for preparing the formula milk. In 
Zimbabwe, while most areas are serviced with running water, it is the safety of this water 
that poses a problem. In 2008, a severe cholera outbreak killed at least 4000 people and 
infected about 100 000 others (31). The outbreak was a direct result of unclean water and 
poor sanitation as the country ran out of purification chemicals for treating drinking 
water. Using such unsafe water for formula milk could hence have devastating results for 
the child.  
 
It is quite common however, to find women practising breastfeeding in conjunction with 
feeding other foodstuff to their child. This form of feeding, also known as mixed feeding, 
is generally regarded as more dangerous than exclusive breastfeeding (32). The danger 















purported that mixed feeding damages this lining making any viral pathogens more likely 
to enter into the blood stream thus increasing chances of HIV transmission. 
Unfortunately, circumstances, such as low volumes of breast milk and a busy lifestyle, 
make it unavoidable to practice mixed feeding for most women in developing nations. In 
the absence of ARVs for the mother and the baby, this could lead to a higher HIV 
transmission rate to children (23). 
1.6.2 PMTCT in Zimbabwe 
Figure 1 shows the PMTCT registered sites in Zimbabwe in 2003. The progress report on 
PMTCT coverage in Zimbabwe showed that only 55% of ANC facilities provided testing 
and ARVs for PMTCT in 2008 (33). 
 
 
PMTCT is integrated into ANC and thus forms an integral part of a pregnant woman‘s 

















































Zimbabwe demographic health survey (ZDHS) (34), meaning a substantial number of 
pregnant women have physical access to PMTCT. However, literature shows a tendency 
for women to drop-out of ANC after their first visit particularly if faced with financial 
constraints or if the individual is found to be HIV positive (35-39).  
 
Whilst it is expected that higher ANC attendance results in higher PMTCT utilisation, the 
availability of PMTCT at ANC services does not seem to guarantee that women will 
complete the use of services. A study carried out in Zimbabwe (11) showed a decreasing 
number of women at each stage of the process from ANC visit to PMTCT drugs as seen 
in figure 2. It is not evident why such a trend is observed, but this declining utilisation 
pattern results in missed opportunities to identify HIV positive women and hence exposes 
women to a higher risk of transmitting HIV to their child. 
 
Figure 2 Trend in utilisation of PMTCT services in Zimbabwe (Mahomva et al 2006) 
 
1.6.3 Potential barriers to uptake of PMTCT 
1.6.3.1 Approach to HIV counselling and testing 
 
Two strategies exist for HIV counselling and testing, the ‗opt-in‘ approach and the ‗opt-
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individual is voluntarily counselled and screened
1
. A study done by Bahwere et al (41)
showed that a more effective way of ensuring more women are tested is the opt-out 
approach whereby counselling and testing is a routine part of the ANC package and 
women make the choice to ‗opt-out‘ if they do not want to be tested. The opt-out 
approach is thought to improve the perception of testing as testing is customary for every 
woman. 
HIV testing is generally perceived as a prescription for speedier death hence causing
much fear and anxiety. In Uganda, people expressed reservations about testing (42). They
feared that knowing one‘s status would speed up death due to worry and stress, and did
not trust staff to keep the matter confidential or that the medication would make them
better. 
1.6.3.2 Difficulty in disclosure 
On the issue of why women who have tested positive for HIV do not go on to take the
preventive drugs, some studies suggested disbelief of results or difficulty in disclosure,
hence preventing the individual from accepting preventive drugs or replacing 
breastfeeding (43). Studies show that an effective way of avoiding difficulty in disclosure
and consequently improving use of and adherence to PMTCT services is involving the 
partner in ANC and PMTCT (44).
1.6.3.3 Poor access to PMTCT
It has been proposed that, while the methods of preventing vertical transmission are
effective, implementing these interventions in sub-Saharan Africa and other developing
areas of the world is difficult due to cultural and economic barriers (45). Worldwide in 
2006 the proportion of HIV positive pregnant women receiving ARVs was only 23%
(46). This low coverage implies there are other barriers to full coverage of populations. In
order to utilize services, women need to have access to the services. Access, as defined
by McIntyre et al (47), is the empowerment of an individual to utilize health services. In
1
 The approach to counselling and testing for pregnant women had been changed to the opt-out approach 















their definition, they propose a framework which incorporates three dimensions of 
access: availability, affordability and acceptability. 
 
Availability refers to physical access, that is, whether or not the appropriate health 
services are available in the right place at the right time (47). Although PMTCT in 
Zimbabwe is integrated into an already existing ANC program, services still need to be 
evaluated to guarantee full physical access to PMTCT. The most frequently identified 
issues pertaining to availability are staff, time, resources and location. Staff shortages and 
low morale can be a significant barrier especially when it comes to counseling. Better 
training, greater support and motivation can improve the efficiency of existing staff. In 
addition to staff, the PMTCT program requires availability of family planning services, 
HIV test kits, preventive drugs and sundries. 
 
Other issues pertaining to availability include the type and range of services available as 
well as the operating hours of the health facility. Where operating hours are concerned, 
women tend to require flexible facility operating hours since they are often faced with 
many responsibilities including caring for their families and working. One programme in 
rural India boosted attendance to ANC by setting up a Saturday clinic as weekday visits 
were difficult for women (48).  
 
Affordability refers to the ability for one to pay for the necessary services and also 
includes costs incurred in the process of receiving health care such as transport. Where 
the distance to the health facility is large and transport costs are high, access can be 
hampered.  
 
Acceptability refers to cultural access as well as the quality of the interaction between the 
provider and the patient (47). It encompasses issues of trust in the provider, the quality of 
services provided, knowledge about the intervention and cultural or social beliefs 
associated with it. The poor quality of services has been cited as the main reason for low 
institutional deliveries in Zimbabwe (34 and 49). Failing to deliver at a health facility 















women may be given their dose of nevirapine upon attending ANC with the expectation 
that should the woman choose to deliver at home she can at least take the drug since she 
already has it (50). However, a study in Zambia found that it does not follow that she 
may do so (51). It was reported that up to a third of those given the drug did not ingest it 
mainly due to concerns about discrimination. 
 
There is also evidence to suggest that the relationship that the patient has with the 
provider affects their ability to utilise services (47). For instance, gender, age or language 
barriers may affect service uptake. Where a woman is addressed by a male provider, she 
may feel uncomfortable discussing ―female‖ issues, or where a much younger health 
worker addresses sensitive issues about sexual reproduction with a much older patient, 
the service becomes culturally unacceptable for the patient and may hinder access to that 
service. 
 
1.6.4 Fragile states: Political climate and economic instability 
 
Health systems have been known to become eroded over time in the face of prolonged 
conflict within a state or in fragile states (52). The presence of conflict, be it politically 
motivated or influenced by ethnicity, leads to disruptions in the supply of quality health 
care as institutions may become run-down and human resources dwindle. Services 
become fragmented and differentially available depending on where conflict-affected 
areas are located. Governmental financial resources may also become scarce as the 
economy declines while individual and household financial resources are challenged due 
to rising unemployment and unstable economy. All these factors affect access to 
healthcare leading to rising morbidity and disease-related mortality. 
 
In Zimbabwe, the political climate has rapidly deteriorated within the last 2 decades 
resulting in increased election-related violence and economic instability (53). Such 
political and economic deterioration can adversely affect the health system and individual 















1.6.5 Conclusion  
Although there is great commitment to expand the coverage of PMTCT, the fact remains 
that the majority of women and infants who require these services do not receive them. It 
is evident that there can be a number of reasons why such a situation may exist. 
Therefore, it is important to establish the cause of failure in order to have more effective 
programs and help in the fight against HIV/AIDS. 
 
1.7 METHODS 
1.7.1 Study site 
Marondera is selected because of the extent of urbanisation and high HIV prevalence. 
The population is diverse in terms of cultures (due to different ethnicity) and socio-
economic status (due to different opportunities to earn income between rural and urban 
areas). This introduces variety in the factors affecting affordability, knowledge about 
PMTCT and utilisation of ANC. Furthermore, the HIV prevalence rate in Marondera is 
quite high at an estimated 30% or more of antenatal attendees (54). This should provide a 
large population in need of PMTCT services. 
1.7.2 Population  
Pregnant ANC attendees at public health facilities (clinics and hospital) 
Inclusion criteria: All pregnant women over the age of 18 at the clinic 
Exclusion criteria: Women at delivery and those unable or unwilling to consent 
A positive HIV status could have been used as an inclusion criterion, however, HIV is 
still highly stigmatised in Zimbabwe and there is no sampling frame from which to 
extract a sample of HIV positive pregnant women. The absence of a sampling frame 
hence makes it difficult to identify and approach HIV positive pregnant women from a 
mixed pool without exposing them to the risk of discrimination. 
1.7.3 Study design 
Both quantitative and qualitative approaches will be used in the research process as this 















sectional survey will be conducted followed by qualitative interviews with providers and 
focus group discussions with women. 
1.7.3.1 Cross-sectional survey 
A cross-sectional survey will be conducted at public health facilities in the district. The 
data collection tool will be a structured questionnaire with closed-ended questions. 
Trained fieldworkers will conduct face-to-face questionnaire-based interviews on all 
qualifying pregnant women visiting the facilities. Each interview is envisaged to last 30 
minutes. The questionnaire will be printed in English and Shona and will have the 
following sections: 
 
Section A: Socio-economic and demographic characteristics of the respondent such as 
age, marital status, occupation, level of education and religion 
Section B: Knowledge about PMTCT 
Section C: Attitudes towards PMTCT services and the acceptability of these services 
Section D: Availability and affordability of PMTCT services 
 
A pilot study will be conducted prior to the final study being carried out. This will 
determine if any areas should be refined on the questionnaire and assess whether the 
questions are set at the right level of understanding. 
 
Sample size 
Commonly the sample size for quantitative studies is calculated based on the desired 
level of confidence and acceptable margin of error (56). Such calculations are made so as 
to reduce uncertainty and enhance the precision of findings thus to be sure findings from 
the sample truly reflect the population of interest. However, the goal of this study is to 
identify various issues pertaining to access that women are concerned with and as such all 
mentioned barriers are considered important. Consequently, the level of confidence and 
the margin of error will not be used in calculating the sample size. 
 
Sampling strategy 






















         
















                                                  Random selection                  
 
- The district will be stratified according to extent of urbanisation into urban and 
rural areas 




































- A hospital will be randomly selected among the 3 hospitals in the district and 15 
women will be interviewed from this site. 
                                                                                                                    
1.7.3.2 Focus group discussions (FGDs) 
A qualitative survey will be conducted in order to validate the information obtained from 
the quantitative survey. The FGD is chosen for this purpose because due to the group 
dynamics that it raises, it has the potential to elucidate information that may not have 
been previously mentioned in questionnaires or information that requires further 
clarification (57). The FGD will also spark interactive debate and generate discussion 
among the women as they see the similar or different concerns their peers have.  
 
Sample size and sampling strategy 
The population will be stratified into rural and urban population groups. Two FGDs will 
be conducted, one in the rural and the other in the urban area, both comprising pregnant 
women who have attended ANC and have been notified by nurses about the potential to 
participate in the FGD. Each FGD is envisaged to be attended by 6 to 10 women which is 
a manageable size and to last approximately 1 hour (57). Key topics in the FGDs will 
include key challenges faced in accessing PMTCT and knowledge about PMTCT. The 
FGDs will be tape recorded and notes will be taken during the discussion in order to 
complement the recorded information. The recorded material will then be transcribed. 
1.7.3.3 In-depth interviews with providers 
In a bid to validate information obtained from FGDs and questionnaires, semi-structured 
interviews will be conducted with health providers at the 5 health facilities. This is a form 
of triangulation, a process of using multiple data collection methods, data sources, 
analysis or theories, in order to check the validity of findings (58). Topics in in-depth 
interviews will include the guidelines regarding PMTCT, the challenges faced in 
providing PMTCT services and the challenges perceived to be faced by women in 
accessing PMTCT services. These interviews will last approximately 20 minutes and will 














1.7.4 Data analysis 
The cross-sectional survey questionnaires will be coded and entered into a database using 
the Epi Info program immediately after completing the interviews. Data will be 
quantitatively analyzed using STATA© 10 to obtain descriptive and analytic statistics. 
Analysis will include univariate and multivariate regression to identify the relationships 
that exist between some variables and access to health services and hence determine 
factors affecting availability, acceptability and affordability. The covariates used in the 
analyses will be selected based on the conceptual framework for access by McIntyre et al 
(47). 
Furthermore, to ascertain the factors affecting affordability of services, an index of socio-
economic status will be constructed through the Principal Comp nents Analysis (PCA)
technique using ownership of household assets (59).
Qualitative analysis of transcribed FGD and provider interviews will be conducted
simultaneously by a team of 3 researchers. Each researcher will independently read the
written comments and transcribed data and group them into themes in a technique called 
immersion/crystallization which forms part of the broader grounded theory approach. It is
defined as a process whereby researchers immerse themselves in the data they've
collected by examining a portion of the data in detail, then temporarily suspending the 
process of examining in order to reflect on the analysis experience and attempt to identify
themes noticed during the immersion process (60). The temporary suspension phase is 
followed by a return to the data, where the reflection process is fed back to the next
immersion phase. These dual processes continue until all the data have been examined
and patterns and claims emerge from the data that are meaningful and can be well
articulated and substantiated. The team will then meet every 3 days to agree upon a
common cataloguing of themes. Multiple reviews will be conducted until saturation is















1.7.5 Ethical consideration 
Ethical approval will be obtained from the research ethics committee at the University of 
Cape Town (UCT) as well as the Medical Research Council of Zimbabwe (MRCZ) prior 
to conducting the study. The research will be conducted according to the ethical 
guidelines and principles of the international Declaration of Helsinki (61). This study 
seeks to determine barriers that pregnant women are faced with in accessing PMTCT 
services in the Marondera district of Zimbabwe. The findings will help formulate 
strategies in increasing uptake of PMTCT services in the future.  
 
Approval to conduct the study will be sought from the head of each health facility. The 
intentions and the importance of the study will be explained to them and details of the 
procedures to be undertaken including potential risks and benefits to the participant will 
be given.  
 
Consent to participate will be sought from individuals selected for the cross-sectional 
survey and the FGDs. Potential participants will be given full details of the nature and 
aims of the study and they will be free to decide whether or not to participate in the study 
without being coerced. Should they decide to partake of the interview, their written 
informed consent will be required. No consequences will be incurred if they decide not to 
take part or not to answer certain questions. Subject codes will be used for identification 
instead of names and any identifying information will be removed from the records and 
will only be accessed by the research team.  The interview process will be conducted in 
an enclosed area to enhance participant‘s confidence and ensure maximum privacy. The 
interview will be conducted in the language chosen by the participant between English 
and Shona. 
 
There will be no financial incentives awarded to participants. However, participation will 
contribute towards implementation strategies of future PMTCT scale-up programs thus 
participants will benefit from improved services in the future which are in line with the 
















Participants may feel vulnerable disclosing their personal experiences and how this may 
influence their reputation in the community. The interviews may provoke anxiety or 
distress as they may be reminded of painful or unpleasant experiences or some 
difficulties they are currently facing. The interviewers will make every effort to respect 
the feelings of participants. All participants will be told that they should feel free not to 
answer questions which they are not comfortable with, or withdraw from the study at any 
time. Every effort will be made to ensure the participant‘s confidentiality is not breached. 
 
Participants will be given contact details, where they can direct their questions either 
relating to the study or their rights as study participants. The benefits of the research will 
be made available to the participants and will be widely disseminated. 
1.7.6 Dissemination of findings  
The final report of the study will be made available to the Health Economics Unit, the 
Swedish International Development Corporation Agency (SIDA), the MRCZ, and the 
Ministry of Health and Child Welfare of Zimbabwe. The findings will also be published 





























1.8 PROPOSED STUDY BUDGET 
Table 2 Study budget 
S/No 
 
Description  Rate  Quantity Cost/$ 
1. 




  Car hire during fieldwork and pilot $35/day 45days 1575 
2. 
Personnel 2 assistants (per diem) $20/day 2×45days 1800 
 




investigator) $30/day 45days 1350 
3. 
Stationary  
Printing and photocopying 
questionnaires $0.07/page 10×250 175 
 
  Photocopying consent forms  $0.07/page 4×250 70 
 
  Clipboards  $5 3 15 
 
  Pencils (2 per person)  $2 6 12 
 
  Erasers(2 per person)  $2 6 12 
 
  Pens(2 per person)  $3 6 12 
 
  Printing of final report 
                      
$0.07/page 10×100 70 
 
 
Binding of final report 
                                    
$5 10 50 
4. 
Translations 
From English to 
shona(questionnaire and consent 









Refreshments during training 








 Miscellaneous Unforeseen expenses 
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2.1 INTRODUCTION TO THE LITERATURE REVIEW 
Maternal and child health are the key indicators of a country‘s health status, level of socio-
economic development, quality of and access to health care delivery services (1). Sub-
Saharan Africa has the highest child mortality rates in the world (2) and also carries 90% of 
the need for prevention of mother to child transmission (PMTCT) of HIV (3). A key focus
has therefore been to reduce the incidence of HIV among women and reduce vertical
transmission of HIV through implementation of PMTCT strategies (3). PMTCT has seen the
rate of vertical transmission falling drastically in some countries due to effective use of anti-
retroviral (ARV) prophylaxis, safe delivery and safe infant feeding practices (4). However, in
some resource limited settings like Zimbabwe the programme has not yet yielded favourable
results: high HIV-specific morbidity and mortality rates continue to be observed (5). By 2004
HIV accounted for an average 10% of child mortality in Africa (6) while in individual
countries such as South Africa and Zimbabwe, it accounted for over 40% of child mortality
(5 and 7). With such high mortality rates, which are avoidable, the general consensus has
been to increase the coverage of PMTCT services. Leading health organisations and
governments have supported and encouraged the expansion of coverage through integration
of PMTCT into existing services such as antenatal care (ANC). However, access to PMTCT 
services remains a challenge for most women in developing countries (8). 
The aim of this literature review is to identify a conceptual framework that will guide an 
empirical investigation of access to health services in general and to PMTCT in Zimbabwe
more specifically.
Because access itself is a key concept in the broader literature related to equity in healthcare, 
the first section of the literature review places access in context within this literature. The last 
section is then a review of empirical literature applying access conceptual frameworks in 
studying access to health care. 
2.2 EQUITY AND HEALTH INEQUALITIES 
Whilst most countries have adopted strategies to increase access to PMTCT services, there 














countries (4). These differences in the use of health care contribute to growing disparities in 
health outcomes, in this case HIV incidence rates among children under five. It is these health 
disparities that have now become central to health policy internationally (9). Increasing 
emphasis is therefore being placed on the causes of these disparities, termed inequalities, and 
how these causes can be overcome. 
The major concern in this section is to provide an overview of types of health inequalities and 
to propose a definition for equity that realistically addresses concerns about the distribution 
and accessibility of health care services. In the following paragraphs the concept of equity is 
argued to be best presented as equal access for equal need as this principle is applicable to all 
types of health services and can be achieved realistically.  
2.2.1 Health inequalities 
Equity has been defined as the absence of disparities (unfair and unjust differences) between
socially advantaged and disadvantaged individuals (10, 11). 
While health is commonly argued to be a basic human right, one frequently observes
considerable inequalities in the health of individuals within and between different societies, 
ethnic or race groups (12-14). Disparities in health are argued to result from differences in
personal, socioeconomic and/or environmental contexts (10, 15). Socioeconomic and
environmental attributes include emplo ment status, educational attainment, environmental 
and occupational exposures and access to basic health promoting services and facilities such 
as safe drinking water, waste disposal and sanitation systems (15). In contrast, personal
attributes include an individual‘s natural predisposition to certain health conditions due to
gender, age or genetic makeup, but also include personal cultural practices affecting health 
and individual behavioural tendencies which impact health (10, 15). Clearly there is therefore
a difference between personally-moulded and socially-constructed differences in health. 
Health disparities arising from socially constructed differences are considered unfair or unjust 
particularly if they can be removed in order to equalise opportunities for health (10, 11 and
15). Researchers often distinguish between health inequalities that are unfair and unjust from
those that are ‗fair‘ or inevitable (10, 11 and 15). It is noted that unfair and unjust inequalities
















2.2.1.1 Health inequities and health service inequities 
While a focus on health inequities is important, responding to these adequately would require 
coordinated action from a number of sectors beyond the health care system. The focus in this 
paper however, is on health services. 
Previously it was mentioned that differences in the level of use of health services between 
and within countries contributed to disparities in health outcomes. This points to a need to 
equate opportunities to utilise health care in order to achieve better health outcomes. Unfair 
inequalities in the distribution and organisation of health services can have detrimental effects 
on one‘s propensity to utilise health services. This can contribute to the surfacing of health 
inequities. 
2.2.2 Principles of equity 
Whilst there has been a call to achieve equity in health and health care, there has not been as 
much consensus as to what principle or definition of equity should be used in addressing this 
goal in order to better enable monitoring progress towards it. Several principles have in fact 
been debated in the literature, all in a bid to explain the fundamentals of equity (16-18). Three 
key principles are commonly discussed: 
- Equal access to health care for those in equal need of health care 
- Equal utilisation of health care by those in equal need of health care 
- Equal health outcomes 
Equal access for equal need suggests that the health care system should afford equal 
opportunities for achieving maximum health for all individuals with the same or equal need 
(16-18). For instance all children should have the same access to the same vaccines necessary 
to prevent ill health. This does not necessarily mean that utilisation will be equal as personal 
choice and preferences might lead to different levels of utilisation even if access is equal (18). 
Similarly, those with unequal need, for instance women and men, should have unequal access 
to healthcare in line with their differing health requirements (vertical equity).  
The principle of equal utilisation for equal need on the other hand discounts the role of 
individual preferences for healthcare (16, 18). In this instance two hypertensive women are 
expected to use antihypertensive services and medication equally since they have the same 
‗need‘. This principle however, tends to override acceptable reasons for unequal use of health 














behavioural tendencies or risk aversions that hinder use of health care (18). This principle can 
only apply for certain but not all health services and in particular, applies where externalities 
exist. For instance, where herd immunisation is necessary to prevent a potentially fatal 
disease such as poliomyelitis, personal preferences are overridden in order to improve future 
population health.  
The last commonly discussed principle is that of equal health outcomes. In this regard all
individuals are expected to attain the same health status (16, 18). Addressing equity in this 
manner would require that more resources are spent in ensuring all individuals have the same 
lifestyle and stringent measures are put in place to restrict personal choices for risky
behaviour such as smoking or eating ‗unhealthy‘ foods. While this approach would be highly
effective in reaching the goal of equitable health, scarce resources at the national level and
freedom of choice at the individual level hinder the probability of fulfilment of equal health
outcomes. Instead it is more practical to equate opportunities to obtain health care for each 
individual (16, 18).
Therefore, this review is in agreement with Oliver and Mossialos (18) who contend that the
best principle of equity in health care for health policy makers to pursue is that of equal
access to health care for those in equal need o health care. In essence this principle means
that in order to achieve equity, health systems need to distribute resources and processes in 
such a way as to equalise the opportunity to use health care for all individuals. Because 
access is often seen to differ according to socioeconomic status, this principle often includes
a focus on equalising opportunities between socially advantaged and disadvantaged
individuals.
2.3 THE CONCEPT OF ACCESS 
Whilst the previous section defined equity as equal access for equal need, this section further 
discusses the concept of access itself. Although there is a fair body of literature on access, 
there is still debate as to what exactly access represents. The following section aims to 
introduce the fundamentals in defining access and presents an argument for the idea that 
access is a multifaceted concept which includes the relationships between dimensions of 
availability, affordability and acceptability of health services. Access is not merely a supply 
side issue i.e. a health delivery system issue, but integration between the individual or 
household (the demand side) and the health system (the supply side). It refers therefore to the 















This section also introduces the reader to a conceptual framework that will be applied within 
this dissertation in order to evaluate access to PMTCT services. A conceptual framework or 
model provides a broad understanding of the phenomena of interest and allows for an 
understanding of how its individual components relate to each other (19 and 20).  In this case 
the phenomenon under study is pregnant women‘s access to PMTCT services and thus a 
framework that provides a broad understanding of access is the subject of interest.  
2.3.1 Access: multi-dimensional and interrelated 
Colloquial definitions of access suggest the idea of ‗a right to or a means of approaching, 
entering, communicating with, exiting and making use of a service or system‘ (21).  This 
description of the term implies the existence of a multitude of pathways, channels and 
resources consumed or spent in order to make a system or service accessible to an individual. 
Similarly, early literature often conceived of access as the ‗entry into the health system‘ (22). 
Entry into the health system however, requires the health system to exhibit certain 
characteristics and for the client to complement these characteristics and vice versa. These 
characteristics include availability, acceptability and affordability. 
2.3.1.1 Availability, acceptability and affordability  
Access is argued to be a multidimensional concept comprising three key dimensions of 
availability, affordability and acceptability, all of which are interrelated and at any level 
influenced by information and knowledge (23-27).  
Researchers Bodenheimer (28) and Freeborn and Greenlick (29) defined access as the 
availability of a service in the right place at the right time. Their emphasis was on the 
physical presence of resources necessary to improve health for an individual or community. 
As can be expected much of access is indeed concerned with the availability of the necessary 
resources including personnel, infrastructure and medicines. This conception leads many 
attempts to increase access to any particular service. As identified in the literature, physical 
access constitutes a very important and necessary step allowing individuals to utilise health 
services (30). The proximity to a health facility is an example of physical availability that can 
pose a great barrier to using health services: studies have shown that people are unlikely to 
travel farther than 5km to preventive and curative care (31). Indeed the location and quantity 














The quantity of resources is particularly important in poor developing countries which are 
ravaged by health-worker migration and drug supply shortages.  In a study conducted in 
Uganda, researchers found that shortages of trained staff, lack of staff motivation, and a 
shortage of materials hindered access to HIV testing and other PMTCT services (32). Similar 
findings were observed in studies in South Africa where women did not receive adequate 
PMTCT services due to what the authors referred to as ―health systems failure,‖ including 
missed opportunities for HIV testing, receipt of the result, and access to nevirapine (33, 34). 
Other health systems failures reported were shortages of supplies and consent forms, lack of 
counsellor availability, and health staff offering incorrect information or education that was 
not well understood by the local population. 
However, it is important to note that availability refers not only to the geographic location
and quantity of services but also the range of services provided (27). A mere count of the 
facilities in an area is not sufficient to conclude that services are available: the services
available must match the needs of the population. This is evidenced in empirical literature,
for example in a study in Sri Lanka, geographic distribution of facilities was found to be
adequate but availability of services for chronic diseases was poor (35). As such people still
reported limited access to services because what they required was not made available to
them. Regarding PMTCT, some of the studies have looked at the type of regimen used in
PMTCT or the type of test used for HIV testing as this affects uptake of PMTCT. Offering 
the rapid HIV test to pregnant women has been found to improve the rate of receiving HIV
test results given that this minimises the potential loss to follow-up of women who do not 
return for their test results when non-rapid testing is used (36).
Essentially, increasing the availability of resources will improve access to health services, but 
others have argued that this does not constitute the full definition of access (22-27). While 
services may have been made available in an area one may still be unable to access these 
services. Donabedien (22) identified what he termed ‗socio-organizational and geographic 
attributes‘ of resources which have the potential to hinder or enable one to utilise health 
services. He argued that the mere existence of services did not constitute access but how 
acceptable they are to the individual using them impacted how accessible they were to him or 
her. These attributes may, for instance, be the presence only of a male provider for female 
services or race and language differences between a doctor and his patient which could pose a 














Consequently, one can identify certain expectations from the health system of an individual
and conversely expectations from the client of the health system. These expectations,
particularly on the client‘s side arise from their own cultural standing (values and beliefs),
attitudes or knowledge regarding the problem at hand (37 and 38). In more recent literature, 
this aspect of access, termed acceptability, has been defined as the social and cultural distance
between health care systems and their users (39). Three elements of acceptability are
described in the literature (39). The first is the fit between lay and professional beliefs which 
govern individual decision making in health seeking. A study in Kenya showcases this (40). 
The study investigated community preferences and characteristics versus supply-side 
characteristics. One of their key findings was that whilst insecticide treated nets (ITNs) for
malaria were distributed free to all households there was a mismatch between the types of
ITNs distributed and the community‘s preference. Lay beliefs were that the white colour and 
rectangular shape of the ITNs represented a burial shroud and a coffin respectively. As such
they associated the ITNs with death and were not willing to use them. On the supply side,
rectangular nets were thought to be easier to use as they fitted around a bed more easily than
round nets.
The second element of acceptability is the way that health care organizational structures and
arrangements frame patient responses to services. This also encompasses the quality of care
received. Tianviwat et al (41) found that while child-dental care was available in mobile 
clinics, parents were willing to incur more costs to attend the regional hospital‘s dental care
unit. The reason for this was the poor quality of services that they experienced with the
mobile clinic relative to the hospital. In essence, without consideration of the quality of
services, availability may only result in marginally increased access to services. This idea
was resonated in Vietnam where researchers sought to establish the difficulties that women
experienced in accessing PMTCT (42). Although PMTCT services were available and
settings that offered PMTCT were well resourced, still, pregnant women experienced barriers
in accessing the services. The researchers discovered that although PMTCT was available,
HIV-infected women did not receive adequate care because of barriers to accessing those
services which included the quality of care and poor testing and counselling services. 
The third element is that of the nature of provider-patient engagement and dialogue. Somers 
(43) identified this as the influence of the doctor-patient relationship: how well the two
parties interact affects how much the client is willing to utilise the services. It is also seen to 















that pregnant women based their health seeking behaviour on previous experiences with the 
health system including negative attitudes from providers. Similarly, lack of trust in providers 
affected utilisation of TB control programmes in Vietnam (46). 
 Another dimension of access brought up in literature is affordability. The affordability of 
services has often been narrowly described as the cost of healthcare at the supply side or 
health delivery system and the income or ability to pay on the demand side or for the 
individual (47). In other words, the literature mainly considers the cost of receiving care that 
an individual incurs at the point of service use. This is also known as the user fees. 
Consequently, efforts to improve the affordability of services concentrate on user fees and it 
is normally assumed that low user fees should result in greater opportunities to utilise health 
care (48, 49).  This is true in most cases. Teeraratkul and colleagues (50) reviewed PMTCT 
programs at two hospitals in Thailand between 1999 and 2001. During the first year of their 
national program, Thailand achieved nearly 70% PMTCT coverage. PMTCT services at two 
large hospitals with extensive maternity services offered routine HIV testing and counselling 
during antenatal care and labour for those who did not present sooner. Women from rural 
areas demonstrated higher access to antenatal care compared with women in urban areas 
(94% vs. 87%). The most frequently cited cause of not accessing antenatal care in this 
population was not having enough money to pay for services (60%). 
There are however, many other costs that an individual incurs when attempting to access 
health care which can deter use of health services. Until recently very little effort had been 
made to broaden the concept of affordability to include these costs. Researchers have termed 
these ‗opportunity costs‘ and ‗indirect costs‘ that the individual incurs upon using the health 
services (27). Opportunity costs refer to the value of the best forgone alternative use of a 
given amount of resources (51). The opportunity cost in seeking health care can be described 
as the income lost due to time spent away from the individual‘s income-generating project 
while seeking health care (27). This type of cost is common where individuals are self-
employed or where one does not have the ability to obtain sick-leave from work. Opportunity 
costs arising from illness and health seeking thus have an impact on the family‘s income 
generating capacity and ultimately on the family‘s disposable income. This sometimes results 
in delays in health seeking in order to meet other monetary requirements for the family such 















Indirect costs are those costs incurred in the process of seeking health care. They include 
transport costs to and from the health facility, cost of food consumed during the time waiting 
to be attended at the facility, cost of hired child-minders who take care of the children at 
home while the parent or guardian seeks health care, and any other costs that the individual 
incurs in the process of obtaining health care. 
2.3.1.2 Access dimensions are interrelated 
Penchansky (47) made an important observation that the dimensions of access cannot be 
easily separated. For example, user fees are commonly associated with the quality of care 
received, the availability of services and the range of services provided (27). It is thus 
impossible to separate affordability from quality and availability of services. The issue of 
user fees and their removal or reduction is thus a subject of debate in many low-income 
countries (53). Although deemed necessary in order to improve the quality of care, user fees 
have often been blamed for increasing inequities in the health system and also for worsening 
poverty (54, 55).  
Empirical literature has shown how the link between user fees and quality, availability and 
affordability works. A comparison of countries that introduced the Bamako Initiative is an 
example. The Bamako Initiative sought, among other things, to improve essential drug 
distribution and introduce user fees in a bid to increase the availability of quality health care 
(56). In Cameroon, it was discovered that facilities that implemented the initiative had 
increasing numbers of people utilising the services (57). In that context, travel and time costs 
incurred in seeking alternative sources of care that was free at the point of use proved to be 
higher than the user fees applied at closer health facilities which had improved quality of 
services. Thus people were more willing to pay for quality drugs rather than pay at alternative 
lower quality sources of care. In essence, introducing user fees led to a sustained increased 
quality of health care, increased availability of medication and increased affordability in the 
sense of indirect and opportunity costs such as time and travel costs. In comparison, in 
Zambia, introduction of user fees led to decreased utilisation of services and reduced access 
to health care (57). Primarily the reason for this was the absence of an improvement in the 
quality of care: the resources generated from user fees were not used to improve quality of 
services. As such there was a decrease in affordability which drove the cycle of decreasing 
utilisation and decreased revenue generation subsequently resulting in a decline in the quality 














Still on the subject of interrelatedness, another study showed the impact that increasing 
availability of facilities had on other dimensions of access. Gottlieb et al (58) sought to 
evaluate the impact of additional or new maternal and child health stations on access to 
antenatal care by women. Although their main focus was on availability, they addressed 
questions of financial access, socio-cultural barriers and health system characteristics by 
including questions on these in the interviews they conducted.  They found that establishment 
of new stations improved physical access to ANC and secondarily diminished other financial 
barriers such as transport costs.  Additionally, socio-cultural barriers which arose from 
needing permission, company and support in order to access distant services, were reduced 
due to closer proximity of facilities thus enhancing women's options for independent 
healthcare-seeking. However, increased numbers of facilities diminished the system‘s 
capacity to contain the workload as there were not enough staff to go round. As such there 
were limited opening hours, staff shortages and communication problems which hampered 
ANC delivery at the new MCH stations.  
2.3.2 Access: degree of fit between supply side and demand side 
One finds that the general theme in defining access is that it can be equated to characteristics
of the population - the demand-side, and characteristics of the health system – the supply-
side. Most literature refers to issues pertaining to both demand and supply side which 
ultimately affect access to the healthcare system (23-27). However, some writers have
distinguished the two saying it is mainly the supply side that has an effect on access (59). 
Their opinion is that access is a ‗supply-side issue and indicates the level of service which the
health care system offers the individual‘. This opinion does not consider demand-side issues
that can hinder or enable one to access health care. Demand-side predisposing factors such as
age, gender, ethnicity or religion can sometimes affect the ability of an individual to access
healthcare. Additionally, one can have enabling factors such as high income or insurance
coverage that enable them to access health care. Furthermore, one‘s attitudes towards and
beliefs about health care and services can affect ability to access health care. Because of this, 
others have argued that access is not merely a supply-side concept (23, 27). 
Whilst there are supply-side and demand-side characteristics that influence access, there also 
is an important link between the two that ultimately determines access. The Aday and 
Andersen framework (23) does not adequately point out these important links or 















more apparent in later models such as the one by Penchansky (47). Penchansky‘s model was 
related to the enabling variables in Aday and Andersen‘s model which constituted the means 
that an individual had available to them in order to use services. 
Penchansky developed the model based on 5 dimensions of access, that is, availability, 
accessibility, accommodation, acceptability and affordability. His model suggested that ‗a 
degree of  fit between the health system and the individuals‘ could be measured across the 
five dimensions of access specifying that the health system and the individual both had 
enabling characteristics within the five dimensions which could result in the individual‘s 
access to the health system.  
His argument then was that there existed some specific areas of fit between the patient and 
the health system. For instance, he described availability as ‗the relationship of the volume 
and type of existing services (and resources) to the clients' volume and types of needs‘ and 
affordability as ‗the relationship of prices of services and providers' insurance or deposit 
requirements to the clients' income, ability to pay, and existing health insurance‘. This means 
that each individual experiences healthcare differently due to their own socio-economic 
standing and personal beliefs, values and attitudes. 
To further explore the relationship between demand-side and supply-side a systematic 
literature review was conducted by Ensor and Cooper (60). The purpose of the review was to 
unpack the demand side characteristics that affected access and how these could be overcome 
through adaptation on the supply side or through targeting the underlying causes. The 
researchers found that frequently identified demand side determinants included the distance 
the individual lived from the facility, their education level, the opportunity cost to accessing 
health care and cultural and social barriers. The study showed that these demand-side barriers 
were at least as important in determining access to services as the services delivered by health 
care providers. In order to improve access to health services, most of the studies reviewed 
proposed that the health delivery system provide services in such a way as to accommodate 
the concerns of individuals. This relates to the issue of the degree of fit between the health 
system and the individual who uses the system. The study showed the ways in which 
demand-side barriers could be overcome by improvement of the supply-side characteristics in 
order to fit the individual‘s needs, yet sometimes it is the demand side characteristics that 















In conclusion, it is crucial to note that a degree of fit must exist between ―characteristics of 
the provider and health services and that of the clients and expectations of clients and health 
providers‖ (25).  
2.4 A CONCEPTUAL FRAMEWORK FOR ACCESS  
Some of the above issues have been addressed in the formulation of an access framework by 
McIntyre et al (27). Similar to other frameworks in the literature, it conceives of access as 
‗the empowerment of an individual to use health care and reflects an individual‘s capacity to 
benefit from services given the individual‘s circumstances and experiences in relation to the 
health care system‘. Thus their argument is that health systems have the goal of ensuring all 
individuals are equally empowered, in other words, have equal opportunities to use health 
services rather than that access is equal to utilisation of health services. This is an advantage 
where health policy is concerned as it moves away from individual preferences in utilising a 




Instead of five dimensions as mentioned by Penchansky, the ‗A‘ framework  as seen in figure 
3, is comprised of 3 comprehensive dimensions where the availability dimension is 
conceptualised as the ‗the right health services being available in the right place at the right 
time‘. Hence this definition absorbs Penchansky‘s dimensions of accommodation, 
accessibility and availability. The model also adopts Penchansky‘s idea of an existence of a 















degree of fit between the client and the health system such that a relationship between the two 
is present in each dimension.  
2.4.1 Availability 
The A-framework proposes availability to be all of 4 aspects: 
- The relationship between the location of health services and the location of the 
population at risk and their access to transport 
- The capacity and willingness of providers to serve the population according to the 
type and severity of their condition 
- The degree fit between operating hours of facilities (design processes) and the times 
that clients need the services to be provided 
- The relationship between the type, range, quantity, quality of services (intervention 
contents) and the nature of health needs of the population. 
This draws focus away from only the physical presence of services as most literature tends to 
imply and broadens availability to be more comprehensive of client needs and health system 
ability to provide for those needs.  
2.4.2 Affordability 
The framework considers the user fees of services and the direct and indirect costs incurred 
by the individual through attaining health care. This reflects an argument that the cost to an 
individual in attaining health care is not merely the fees paid at the point of service use but 
also the cost of travelling to the facility, food consumed while awaiting attention, cost of 
child minders left caring for children at home, cost of lost income or productivity while 
seeking health care and many other costs incurred by the client.  
The term affordability also implies ability to pay. As such the concern in this dimension is 
also the ability for the client to incur the full cost of health care. One can thus expect that this 
ability is dependent on the income of the client, the disposable income after incurring 
mandatory daily living expenses, the possession of health insurance covering illness 
occurrence, the existence (and the awareness) of an exemption facility, the availability of a 
flexible payment mechanism (the design process) and the ability of the client to incur indirect 
costs through substitution of labour during illness or acquisition of sick leave benefits to 














It is thus concluded that affordability is the degree of fit between the full costs to the client 
and the client‘s ability to pay ‗in the context of the household budget and other demands on 
that budget‘ (27).  
2.4.3 Acceptability 
Here the framework relates to Donabedien‘s concern for the socio-organizational attributes of
the system that hinder or enable one to gain ‗entry into the health system‘. However, it does 
not only look at the supply side attributes but considers the degree of fit between the provider 
and patient attitudes towards and expectations of each other as well as trust in each other. For
instance, adolescent pregnancies have in the past attracted attention because of the friction
between providers and clients (61, 62). In this case, the provider judges the client according 
to her age and subsequently develops a negative attitude towards the client and becomes less 
accommodating to the individual. On the other hand, the client expects the provider to treat
her respectfully and undertake a thorough examination of her pregnancy and to explain fully
the stages of her pregnancy. This lack of ‗fit‘ affects the client‘s ability to receive care, let
alone acceptable care and hence the young woman may not access care. 
2.4.4 The role of information 
Information in the ‗A‘ framework cuts across all dimensions of access informing needs-based
resource allocation by planners, informing communities about the availability of services, 
informing individuals about exemptions and acceptable payment mechanism and informing 
providers about cultural beliefs and values of communities which may affect acceptability
patterns. Researchers such as Goddard and Smith (59) and Andersen and Aday (23) have
previously voiced the importance of information and education in their work on access.
2.4.5 Interrelationship between dimensions 
Finally the framework proposes the presence of interrelationships that exist between the 
different dimensions. The model by Andersen and Aday recognised links between the 5 
components of access (health policy, characteristics of health delivery system and those of 
the population at risk, utilisation, and satisfaction) but did not show the interconnected nature 
of the actual dimensions of access. The A-framework enables one to recognise that one 
aspect of access cannot be addressed without possibly affecting the other. Where availability 
is increased affordability may be decreased and where affordability is decreased acceptability 














2.4.6 Limitation of the ‘A’ framework 
Although the ‗A‘ framework tries to capture the broad picture of factors that influence access,
the role of government and policy design and processes is not considered thoroughly as a
major determinant of access. What degree of access is reached along the three dimensions
depends largely, as some researchers have noted, on the interplay between the health care
services and the broader policies, institutions, organizations, and processes (PIOP) that 
govern the services (64, 65). These may also be referred to as policy-level barriers. For
instance policies restricting who conducts an HIV test, where drugs are dispensed from
(whether centralised or decentralised), or which drug regimen is first-line, inadvertently
affect access. These barriers are neither supply nor demand-side barriers but immensely
contribute to failure to provide and abtain the necessary health care. In the face of political or
economic instability, the policy-level barriers may be exarcerbated due to decreased capacity
to instigate change in the PIOPs. Therefore in investigating access, it would be worthwhile to 
determine what PIOPs govern health services as this determines how services are provided.
2.5 APPLYING THE ‘A’ FRAMEWORK 
In coming up with policy relevant solutions, researchers often seek to find out the underlying
issues that influence factors associated with access. However, operationalizing the conceptual
framework for access by beginning with considering all the underlying issues that could 
impact access may prove a difficult and potentially overwhelming task (27). Hence 
researchers employ the more systematic approach of starting with the three dimensions as
entry points into exploring access.
The studies reviewed showed this common starting point by breaking down access into its 
three main dimensions of availability, affordability and acceptability. Following this they 
then identified the factors influencing access in each dimension and asked questions which 
investigated the possibility of constraints to access in each factor. An example of this is a 
study by Akweongo (66), which investigated access to malaria treatment in Ghana. The 
researcher collected information through a household survey on factors that determined 
access such as cost of transport, distance to facility, and variables referring to the cultural and 
religious beliefs of households. Upon analysing the data, she then identified access factors 
relevant for each dimension by conducting regression analysis for each dimension of access 
separately. For instance to identify factors relevant for availability, variables such as the 















variables in the regression and the statistically significant variables then retained for further 
analysis. Using principal components analysis, factor scores were generated for these 
variables in order to actually ‗measure‘ the respective dimensions of access.  
Other studies have used a less quantitative method and instead sought to describe access 
factors. The study by Chuma et al (40) is an example of this. They conducted a cross-
sectional survey and focus group discussions to elicit qualitative descriptions of barriers to 
access. Interviews with individuals and health providers elicited both the constrained factors 
in each dimension of access and the underlying issues influencing each factor.   
Goudge et al (67) sought to investigate the factors enabling or constraining access in each 
dimension by conducting interviews with chronically ill patients in order to document the 
individual‘s socio-economic status including information on their culture, income and 
education, which were seen as variables that could influence one‘s ability to access health 
care. In addition the interviews extracted the individual‘s perspectives of health care and also 
exposed the role that other household members and the broader social network played in 
influencing health seeking behaviour. They then made use of patient diaries and illness 
narratives to capture descriptive textual data about the household‘s interaction with the health 
system. Data included the experiences people had relating to the affordability, availability 
and acceptability of health care and this allowed the researchers to identify and explain the 
utilization patterns exhibited by patients. All this information that they collected included 
factors influencing each dimension of access and underlying issues that could influence these 
factors. Therefore, through application of the ‗A‘-frame, the study identified the key areas 
which needed to be addressed by health policy in order to improve access for the chronically 
ill. 
In conclusion, the studies showed that it was possible to measure or describe access using a 
similar conceptual framework of access by carefully identifying factors of interest for a 
particular intervention that contributed to the different dimensions of access. They also 
showed how one could investigate the relationship between the health system and the 
individuals who used the health system and how the framework could be used in identifying 
underlying causes for constraints to access and thus inform policy. Thus with this knowledge 
in mind it is possible then to assess the barriers that pregnant women face in accessing 
PMTCT services in Zimbabwe utilising the A-framework. The study‘s objectives are to 















acceptability of PMTCT services. The study furthermore intends to determine the factors 
associated with each of the dimensions of access. Guided by the concepts and conceptual 
framework defining access in this literature review, we can conclude that availability entails 
an investigation into the regimens available, the availability of HIV test kits and HIV test 
results, the suitability of operating hours of facilities and the availability of transport and the 
distance to the facilities. Similarly, assessing the affordability of services will entail 
investigation of the prices of services and the payment methods accepted, while assessing 
acceptability of services entails investigating the relationship between staff and patients and 
assessing knowledge entails investigating knowledge about PMTCT. Furthermore to 
determine factors associated with each dimension of access requires investigating the 
participants‘ demographic, socio-economic and geographical circumstances and thus 
identifying possible relationships between their characteristics and the constraints to access or 
knowledge that they exhibit. This will ultimately identify whether any inequities exist in 
access to PMTCT. 
 
2.6 Summary 
This literature review discussed issues pertaining to equity and access to health care and 
identified the conceptual framework for studying access. It also reviewed empirical literature 
that applied the conceptual framework of access in studying barriers to accessing health 
services.   
Improving access to core programmes such as PMTCT could have a dramatic impact on the 
reduction of HIV-specific child mortality. Yet many interrelated factors are at play in 
determining access to services. Subsequently, it is important to consider all dimensions of 
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MANUSCRIPT OF AN ARTICLE 
 
3.1 ABSTRACT 
BACKGROUND: Although Zimbabwe has invested in nationwide scale-up of prevention of 
mother to child transmission (PMTCT) services, high HIV-specific under-five mortality rates 
continue to be observed. This study aimed to document the potential reasons for low PMTCT 
uptake by examining factors constraining access to PMTCT services. 
METHODS: A cross-sectional facility-based survey based on structured face-to-face 
interviews (n=70) was combined with qualitative research that included two focus group 
discussions with pregnant women and 5 in-depth interviews with providers at antenatal care 
(ANC) clinics in Marondera. 
RESULTS: Financial constraints played a major role in access to care. Sixty-seven percent 
of the women reported financial constraints barred them from utilising ANC services and 
facility-based delivery which are the entry points to accessing PMTCT.  Results showed a 
statistically significant positive correlation between wealth index and ability to pay for 
services (p<0.001), thus implying access to services is according to ability to pay, rather than 
need for services. Knowledge about PMTCT also played a role in women‘s ability to access 
and exercise PMTCT. Lack of knowledge was related to poor communication and inadequate 
information from health providers. Low quality of care including poor provider-patient 
interactions and generally unclean facilities were mentioned as deterrents to the use of 
services in some facilities. In addition, physical access to health facilities was limited in rural 
areas due to long distances and lack of transport.  
CONCLUSIONS: Scaling up PMTCT services through integration into ANC can only be 
effective in achieving universal access if barriers faced by prospective clients are considered. 
Results suggest that key improvements would include examining alternative financing 
mechanisms that do not deter patients such as pre-payment mechanisms. In addition, while it 
is important to improve the state of health facilities, it is also necessary to find ways in which 
providers can engage with women in a way that improves the acceptability of services and 















3.2 BACKGROUND  
Vertical transmission of HIV is directly responsible for 90% of childhood HIV 
infection in Sub-Saharan Africa (1). Without any intervention there is a 20-45% chance of 
this transmission occurring (2). However, by implementing the prevention of mother to child 
transmission (PMTCT) strategies which include antiretroviral (ARV) prophylaxis, ensuring 
safe delivery and safe infant feeding practices, the risk of transmission can be reduced to as 
little as 2% (3).  
The possibility of such a great risk reduction is the drive behind much political and 
scientific advocacy towards implementing PMTCT strategies (4).  However, a major 
challenge faced by developing countries is increasing access to PMTCT (5). United Nations 
member states set targets in 2001 in an agreement called the UNGASS declaration to ensure 
that by 2010, 80% of women accessing antenatal care (ANC) ould have access to 
information, counselling and other HIV prevention services available to them (6). This has 
therefore seen the PMTCT programme expanded in most resource-poor settings through 
integration into existing ANC services (7).  
Whilst most developing countries have implemented PMTCT (8), HIV specific child 
mortality rates continue to be high relative to targets set in millennium development goal 4 
(MDG 4) of reducing child mortality (9). In Zimbabwe, the last recorded rate showed that 
40% of deaths in children under the age of 5 were directly as a result of HIV/AIDS (10). 
Although PMTCT has been scaled-up, at least 60% of the women in need of PMTCT are still 
not being reached (11). It is not evident whether women have adequate access to the PMTCT 
services in the first place and if so, if this access is equitable, that is, that there is no 
differential access due to lack of income, differences in ethnicity, sex, age, religion or any 
other factors not directly related to the need for PMTCT (12). This study therefore aimed to 
identify potential barriers to access that could impact utilisation of PMTCT services. 
Attempts to increase access to PMTCT in Zimbabwe have seen the introduction of 
free HIV counselling and testing in clinics; free ARV prophylaxis for HIV positive pregnant 
women (single dose nevirapine for mother during labour, and for baby at birth); and 
counselling on breastfeeding options (13). At the time of the study, the guidelines on HIV 
counselling and testing had shifted away from the voluntary ‗opt-in‘ approach to the ‗opt-out‘ 















adopted from other countries such as Botswana where the opt-out approach had improved the 
numbers of women testing for HIV (14).  
While current measures should improve access to PMTCT services, there remains a 
potential for other issues to impact access. Studies have shown that individual, health system 
and external factors can affect access to health services (15-20). These include individual 
perceptions towards health and health services, individual ability to afford health care and the 
availability of health services and resources for health. Access has thus been described as a 
broad concept which can be measured using 3 dimensions: affordability (financial access), 
availability (physical access) and acceptability (social and cultural access) (20).  
Zimbabwe has experienced changes across some of these dimensions. Structural 
adjustment programs introduced in the early nineties to reduce government expenditure saw 
the introduction of user fees for health services (21). Declining real expenditure in health care 
led to the deterioration of health services, poor maintenance of facilities and high staff 
attrition. By May 1996 antenatal fees in the public sector were pegged at between Z$60 and 
Z$250 (equivalent to US$6 to US$25) depending on the level of the health facility (22). 
Hyperinflation, sparked by increased money supply in the early 2000s, drove prices of 
commodities and services beyond the reach of many (23). By 2008, unofficial rates were such 
that the private sector, the only services available at that time, charged US$20 for 
consultations whilst delivery fees were as high as US$1000 (24, 25). Unfortunately much of 
these health care payments were direct out of pocket payments with a minority (10%) of the 
population benefitting from medical aid obtainable through employment in the formal sector 
(22). Ultimately, many aspects of access were compromised due to policies and contextual 
factors affecting the health system and individuals. It is obvious therefore, that a lot of 
adjustments need to be made in order to improve access to services.  
This study assesses pregnant women‘s access to PMTCT services by looking at the 
availability, affordability and acceptability of PMTCT services. It adopts an analytical 
framework that explores demand, supply and policy level barriers across the 3 interrelated 
dimensions of access (20). The framework also conceives of information as an element 
cutting across all 3 dimensions which is a pre-requisite for promoting good interactions 
between the health system and the individuals (17 and 20). Information also empowers 
individuals to make fully informed decisions about health care (17 and 20). Finally, the 














influence utilisation of PMTCT services, an understanding of which is essential for 
generating concrete policy recommendations. 
3.3 METHODS 
3.3.1 Study site and population 
The study was conducted from January to April 2010 in the Marondera district of the
Mashonaland East province of Zimbabwe. The district has a population of approximately 154 
677 (26) and was purposively selected to represent the variable socio-economic and socio-
cultural differences that exist throughout the country. It is a multi-cultural area that includes
several different tribal groups (27). Rural inhabitants are predominantly involved in small
scale trading and indigenous farming activities while urban dwellers are involved in
commercial farming. 
Marondera is also characterised by high HIV-prevalence among ANC attendees with an
estimated 30% testing positive for HIV (28). This makes PMTCT need relatively high in the
district and hence provides a significant base to conduct the study. 
Since PMTCT is delivered through ANC services in Zimbabwe the study was conducted at
public health facilities offering regular ANC services in the district. There are in total 3 
hospitals, 7 clinics, and 4 rural health centres in Marondera (26). The facilities chosen for the
study were first divided into rural and urban clinics to represent the different socio-economic
groups and different health care access realities in the district. Two clinics from each group
were then randomly selected. A hospital was included as the fifth facility in the analysis as
women were referred there from rural health centres and clinics.
Since the main aim of the study was to provide an overview of the factors facilitating or 
hampering access to PMTCT, the intended users of the PMTCT programme, pregnant 
women, were selected as possible participants. Women under the age of 18 were excluded as 
they were not legally capable of consenting to participate in the study without parental 
guidance. Due to low turnout of pregnant women at facilities, all pregnant women attending 
ANC were approached to participate in the study. Seventy-two women were approached. 















3.3.2 Data collection 
A cross-sectional survey drawing on both quantitative and qualitative data was conducted 
within public health care facilities in the Marondera district. Structured questionnaires were 
used to collect quantitative data from pregnant women and these were administered by 
trained interviewers in the style of a face-to-face interview. This method was adopted to 
afford women an opportunity to ask for clarification rather than leaving questions 
unanswered and also to avoid low response rates associated with self administered and 
return-mail survey questionnaires (29). The questionnaire was developed and piloted on 15 
pregnant women in Harare, Zimbabwe. The original questionnaire was then reviewed and 
modified based on the findings from the pilot study. The questionnaire was translated into 
Shona (the main local language in Marondera), and then back translated into English to 
ensure fidelity of translation.   
Three trained researchers conducted the interviews for an average of 30 minutes per woman. 
Survey questions were grouped into 4 categories: socio-economic and demographic 
characteristics of the respondent including age, occupation, education and religion; 
knowledge about PMTCT including stages at which HIV can be transmitted to a child and 
methods of preventing this transmission; attitudes towards and the acceptability of PMTCT 
services including women‘s acceptance of the way in which PMTCT is delivered; and factors 
associated with the availability and affordability of PMTCT services. 
Focus group discussions (FGDs) with women and semi-structured interviews with health care 
providers were also conducted to obtain additional information not identified in the 
quantitative survey. Two FGDs were conducted, one in the rural and the other in the urban 
area both comprising pregnant women who had attended ANC and were notified by nurses 
about the potential to participate in the FGD. The urban FGD was attended by 8 participants, 
while the rural FGD comprised 7 participants. Topics in the FGDs included key challenges 
faced in accessing PMTCT and knowledge about PMTCT. The FGDs were tape recorded and 
notes were taken during the discussion in order to complement the recorded information. The 
recorded material was then transcribed. 
Semi-structured interviews were conducted with health providers such as nurses in charge of 
clinics, HIV/AIDS counsellors and those responsible for maternal and child health, at the 5 
participating health facilities. Key topics in the interviews included the guidelines regarding 















be faced by women in accessing PMTCT services. These interviews were also tape-recorded 
and transcribed. 
3.3.3 Data analysis 
Coded data from the quantitative survey questionnaires was entered and cleaned using the 
Epi Info program immediately after completing the interviews. Both descriptive and analytic 
statistics were obtained from these data through use of the statistical software STATA© 
(Version 10). Analysis included univariate and multivariate regressions which were 
conducted to identify the relationships that existed between some variables and access to 
health services. The covariates used in the analyses were selected based on the conceptual 
framework for access by McIntyre et al (20).  
To assess affordability of services, an analysis on the existence and/or extent of catastrophic 
health payments was conducted. If the health care expenses are large relative to the resources 
available to the household, this disruption to living standards is considered catastrophic (30). 
The idea is that spending a large fraction of the household budget on health care must be at 
the expense of the consumption of other goods and services. Whilst longitudinal data is 
normally used to estimate the extent to which living standards are seriously disrupted by the 
purchase of medical care, this was not possible to assess in the given cross-sectional study. A 
ratio of health payments-to-income was instead calculated in which payments were 
considered catastrophic if they exceeded some fraction of the household income within a 
certain period (the full gestational period in this case) (31). Generally 5% to 10% of income 
is considered to be mild catastrophic expenditure whilst 15% to 40% are considered moderate 
to high.  
An index of socio-economic status (SES) was constructed through the Principal Components 
Analysis (PCA) technique using ownership of household assets (32). To avoid clumping and 
truncation (wereby households are grouped together in a small number of distinct clusters 
(clumping) or an even distribution of SES is spread over a narrow range making 
differentiating between socio-economic groups difficult (truncation)), several variables were 
used including housing characteristics such as roof material and wall material, access to 
utilities and infrastructure such as source of drinking water, energy and sanitation facilities, 
and durable asset ownership such as ownership of a car, truck or bicycle (32). Indices were 
constructed separately for rural and urban areas to avoid misrepresentation of wealth. For 















same assets do not have value in urban areas. Therefore to avoid making all rural dwellers 
appear less wealthy than urban dwellers, the indices were constructed separately.  
Knowledge about PMTCT was assessed through a short test included in the questionnaire. 
Where women answered the question correctly they were given one point. Where they 
answered incorrectly or were not sure they received no points. The result was then converted 
into a percentage for each participant. 
Qualitative analysis of transcribed FGD and provider interviews was conducted 
simultaneously by a team of 3 researchers. Each researcher independently read the written 
comments and transcribed data and grouped them into themes in a technique called 
immersion/crystallization which forms part of the broader grounded theory approach. It is 
defined as a process whereby researchers immerse themselves in the data they've collected by 
examining a portion of the data in detail, then temporarily suspending the process of 
examining in order to reflect on the analysis experience and attempt to identify themes 
noticed during the immersion process (33). The temporary suspension phase is followed by a 
return to the data, where the reflection process is fed back to the next immersion phase. These 
dual processes continue until all the data have been examined and patterns and claims emerge 
from the data that are meaningful and can be well articulated and substantiated (33). The 
team then met every 3 days to agree upon a common cataloguing of themes. Multiple reviews 
were conducted until saturation was reached and the key themes were extracted. 
3.3.4 Ethical considerations 
Prior to the research being conducted, ethical approval was obtained from the University of 
Cape Town (UCT) Research Ethics Committee in South Africa and the Medical Research 
Council of Zimbabwe (MRCZ). Written informed consent was obtained from all participants 
after explaining the purpose and objectives of the study. The interviews were conducted 
privately and anonymously. After each interview researchers provided the participants with 
more information about PMTCT and access to services in order to clarify misconceptions and 















3.4.1 Demographic characteristics 
Figure 4 Tribal origin of respondents 
A total of 70 questionnaires were successfully completed. The women were aged between 18 
and 44 years of age with a mean of 25.6years. Fifty-two percent of the women were from 
urban areas while the remaining 48% were from rural areas. Altogether, 8 tribes were
represented in the study with the majority being Mazezuru, while other women were of
Malawi descent and Mozambique descent (figure 4).
As shown in figure 5, the majority of women were of the Christian religion with a minority
Muslim and non-religious group. Most of the Christians were from the Apostolic sect, known






















Table 4 represents the socio-economic status of the respondents.  
Table 4 Socio-economic variables 
Variable  Category  Number  % of sample 


























































The majority of respondents had achieved secondary education as their highest level of 




Other Christian Pentecostal 















3.4.2 Affordability and availability 
3.4.2.1 Affordability  
Table 5 shows the results of the assessment of women‘s financial access to health care. 
Table 5 Financial access to health services 
Variable  Yes 
% 
Do you have to pay for health services during your pregnancy?  97.1 
Do you find that paying for health care is difficult? 60.3 
Is the total cost of seeking treatment too high? 67.6 
Is the cost of transport to the health facility too high? 28.9 
Did you have to borrow any money during your pregnancy in order to pay 
for health care? 
18.6 
Did you have to sell any assets during your pregnancy in order to pay for 
health care? 
14.3 
If you have medical aid, can you use your medical aid to pay for health 
services? 
3.7 
Do you have access to any exemptions? 4.29 
In total 60.3% of the women said that health service charges were a burden. When 
considering the cost of seeking healthcare, including transport, purchase of medicine, 
purchase of food during the time spent at the facilities and payments to child minders, among 
others, the proportion of those saying payments were difficult was 67.6%.  
FGD participants expressed similar sentiments. Although PMTCT services were offered free 
of charge women still found it difficult to benefit from them because of the cost of ANC and 
delivery. Furthermore, the referral system made women incur even more expenses, ‘First we 
pay at the clinic $80 then later...we are told to book with the hospital. Here, they don’t 
consider that we have paid before. We have to pay another $50 here to book (for) maternity 
and then $5 each time we come for ANC’.   
Up to 96.3% of the women with medical insurance could not use it to pay for health care 
because facilities mainly accepted cash as the means of payment. Consequently the majority 















spent on out of pocket payments for health care according to wealth (OOP variables were 
converted to a monthly figure by spreading the cost of delivery and ANC visits over the full 
gestation period). 
 
Figure 6 Out of pocket payment share of total monthly expenditure 
Results show that the share of OOP expenditure in relation to monthly household expenditure 
is generally higher for poorer households than for richer households, suggesting a regressive 
nature in OOP payments. 
 






































































Figure 7 shows that over 34% of households are making OOP payments for ANC and 
delivery that exceed 5% of their total household expenditure, while 8.5% exceed the 10% 
threshold. 
Table 6 Multivariate analysis of factors affecting affordability: logit regression model  
 Cost of seeking treatment is a burden 
vs. not a burden 
b
 
Variable  Category  β p-value 
Wealth index  -3.603 0.000* 





Monthly expenditure  -.123 0.31 


































 β regression coefficient; 
b
 base category; *statistically significant at 10% level 
A multivariate logit regression of factors affecting affordability showed that only the wealth 
index, marital status and household size determined whether women reported that the cost of 
seeking treatment was a burden. 
Table 6 shows that as wealth index increased women were less likely to report that cost of 
seeking treatment was a burden. Women who were married were also less likely to report that 
the cost of seeking treatment was a burden as opposed to unmarried women. Finally as the 
household size increased, women were more likely to report that the cost of seeking treatment 
was a burden. The employment status of the woman or the household head had no effect on 
the woman‘s ability to afford services. Possession of medical aid also had no effect on the 















3.4.2.2 Availability  
In terms of availability, the most frequently cited problem was the opening times of the 
facility and secondly the availability of transport as shown in table 7. 
Table 7 Reasons for failing to access healthcare when in need of it 
VARIABLE  Yes  % 
Opening times are inconvenient 34.3 
Transport is a problem 27.1 
Absence of drugs/ resources 25.7 
Distance too long 22.9 
Waiting time too long 22.8 
Absence of health provider 18.6 
 
The absence of resources such as medicines or HIV test kits was another problem women 
encountered. FGD participants reported that frequent stock-out of the rapid result test kits 
hindered those wanting to be tested for HIV from being tested. Women would be told to 
come back for the test another day or be referred to another facility.  
Almost a third of the rural-based women reported that the distance to the nearest health 
facility was a hindrance to their accessing health services whilst only 13.5% in the urban 
areas reported this problem. The time it took to walk to the facility ranged from 5 minutes to 
180 minutes (3 hours) averaging 70 minutes in rural areas and 36 minutes in urban areas. 
3.4.3 Attitudes and acceptability 
Several questions were posed in the questionnaires to unpack the acceptability of services.  
The results are shown in table 8. 
Although the district comprised of diverse cultures and religions, neither culture nor religion 
reportedly disallowed usage of conventional allopathic medicines. Respondents were also 
receptive to the idea of taking prophylactic therapy for PMTCT and 87% believed it was 
effective in preventing HIV transmission. Fifty percent of respondents who either thought 
that prophylactic therapy for PMTCT was ineffective or did not know, found out about 














Table 8 Acceptability of services 
Variable Category Percentage 
















































From FGDs two main themes were found as affecting acceptability of services: the quality of 
services and the health-worker‘s attitude.
Generally women were not pleased with the quality of services at health facilities particularly
at the hospital. They reported that there was a lot of disorganisation and services did not flow
smoothly. In addition, women viewed the level of cleanliness of the facilities, particularly
lavatories and delivery wards, as unacceptable, ‘unless I’m really forced to, I don’t consider 
to deliver my child here...the toilets are so dirty and the floors so wet and slippery.’
Regarding health-worker attitudes, lack of adequate personalised care and professional 
attention was the main cause for concern. Health workers were reportedly rude and 
unsympathetic: 
I came with my mother-in-law to get her tablets. We had difficulties getting transport from 
the rural areas to here so she was now out of drugs. When we arrived it was late in the 
afternoon and although the dispensary was open, they wouldn’t allow her to take medication 
because that section was closed for the day. Even after explaining the situation, they were so 















another transport problem and also delay in her taking her pills. So even though the 
medication was available, we couldn’t get it’ 
Statistics showed that 58% of the women thought staff attitudes towards patients were good 
whilst the remainder believed there was room for improvement. Additionally, quite a 
substantial proportion of women believed health providers offered little or no support 
regarding advice and education as seen in table 9. 
Table 9 Health workers' support 








Health providers assist with education 
And counselling 
10.0 28.5 28.5 33.0 
Health providers assist with advice 
 
7.0 34.0 30.0 29.0 
Health providers identify and monitor  
Complications related to pregnancy 
3.0 25.0 36.0 36.0 
 
Women also reported that they did not trust health workers. Staff working at the district‘s 
ARV dispensary which provided ARVs for the district reportedly publicized the names of 
those who regularly took their ARVs there, ‘as soon as someone new comes to take their 
medicines there, they are already announcing her status to the whole district. If I was to test 
positive today, I wouldn’t get my medicines there’.  
Others were concerned about the pre and post test counselling, saying it was, ‘too serious’, 
and for others ‘not effective at all’ saying it did not prepare them for the result nor did it 
reassure them. Statistics showed that of those who were not satisfied with counselling, 37.5% 
of the women were not happy with the manner of communication, 37.5% were not happy 
with the lack of privacy in the environment, and 62.5% thought that inadequate information 
was given. 
3.4.4 Knowledge about PMTCT  
Most FGD participants were aware of PMTCT although they were not sure about the stages 
at which HIV transmission could occur. They described PMTCT as taking drugs at delivery 
and exclusively breastfeeding the child.  
Some women raised concerns about the lack of adequate information given during 
counselling citing this as a reason for not knowing much about PMTCT. Statistics showed 















and PMTCT respectively at ANC. FGD participants thought the inadequacy of information 
was reason enough for women to seek information elsewhere. Statistics showed that 
altogether 24.3% of participants had learnt about PMTCT through media or from relatives 
rather than from clinics.  
There was also a level of dissatisfaction about the information provided regarding 
breastfeeding options. The general notion was that exclusive breastfeeding should carry a 
higher risk of transmission since the child ‘sucks more of the infected milk’, whilst giving the 
child only a little breast-milk should carry far less risk and replacement feeding carry no risk. 
 
A short test was included in the questionnaires to evaluate women‘s knowledge about basic 
PMTCT. Questions included those represented in table 10. The results of the test are shown 
in table 11. 
Table 10 Respondents' knowledge about vertical transmission 





HIV can be transmitted from mother to child 97.1 0.0 2.9 
It can be transmitted during pregnancy 48.6 35.7 15.7 
It can be transmitted during delivery 90.0 1.4 8.6 
It can be transmitted during breastfeeding 82.9 7.1 10.0 
It can be transmitted during daily activities of washing, touching or 
bathing the child 
 
2.8 78.6 18.6 
There is medication to prevent HIV transmission to child 89.9 1.4 8.7 
Taking medication reduces risk 87.5 1.6 10.9 
Delivery by c-section reduces risk 42.9 14.3 42.8 
Replacement feeding reduces risk 90.0 2.9 7.1 
Mixed feeding increases risk 50.0 20.0 30.0 
 
The average test result was 67% and results ranged from 16.7% to 100%. In total 35.7% of 
















Table 11 Test results: knowledge about PMTCT 
Test result/% Frequency Percent  Cumulative percent 
<50 (poor) 7 10.0 10.0 
51-65 (fair) 18 25.7 35.7 
66-75 (good) 21 30.0 65.7 
>75 (excellent) 24 34.3 100.0 
 
Multivariate analysis of factors affecting knowledge was performed using ordered logit 
regression. The dependent variable was the level of knowledge depicted by the test results as 
categorised in table 11. Results of the analysis are shown in table 12. 
Table 12 Factors determining level of knowledge 
 Knowledge level 
Variable Category β p-value  
Age   .071 0.615 






















Wealth index  .065 0.210 






























Level of health provider support in 













β regression coefficient; 
b
 base category; *statistically significant at 10% level 
The results showed that the source of information on PMTCT, the decision-maker regarding 
health care use and the level of health provider support in counselling and education were 
important determinants of the woman‘s level of knowledge. Greater provider support in 
education and counselling were associated with better levels of knowledge, whilst the woman 














knowledge about PMTCT. Additionally, if the woman was informed about PMTCT through 
media or from a health facility she was likely to have more knowledge than if informed by 
friends and relatives. 
3.4.5 Provider’s perspective on barriers to accessing PMTCT 
Lack of resources 
Providers were asked what constituted the greatest barriers to women accessing PMTCT. The 
main theme emerging was the issue of unavailability of resources. 
‘Resources are the greatest hindrance to performance. Rapid test kits run out and it becomes
a problem when we keep sending away people. We tend to prioritise on the kits however,
starting with pregnant women...But even then, some miss out. For example, out of 56 women 
registered for ANC in the last 2 months, 39 were tested and the majority of those not testing
failed to do so because of unavailability of kits.’
The same problem was faced in provision of drugs. The medicine was donated by a non-
governmental organisation, but frequent stock-outs were reportedly hampering efforts to 
reduce mother to child transmission of HIV. 
Late registration: Low frequency of follow-up tests and visits
Most women attending ANC were reportedly in their last trimester. Providers explained that
HIV negative women failed to return for testing after the window period making it difficult to
exercise PMTCT since their status was not known.
The rate of return of these women for a follow-up test after 3 months is very low and difficult
to monitor as most are at home by then or in different facilities or wards. As such one cannot 
accurately estimate the number of HIV positive women through looking at ANC records. The
value could be much higher because we don’t know what is happening to them after their first
visit. 
They can’t afford 
Providers reported that maternal care charges had affected services. ‗Our pregnant women 
are failing to afford these services. We have seen a gradual decrease in the number of women 
attending ANC and even those delivering here. Because booking payments are no longer 















come. Fortunately a lot of TBAs (Traditional Birth Attendants) are being trained mainly 
recruited from ZINATHA (Zimbabwe national traditional healers association) and the 
apostolic faith sect. These are the people who then assist in home deliveries to ensure safety 
of the baby’. 
Failure to carry out instructions 
Whilst women were provided with the tablet upon testing positive, reportedly, not all of them 
went on to take the drug. Worse still, most women failed to come to the clinic within 3 days 
of giving birth to allow for the child‘s prophylactic dose.  
‘You see, perhaps it’s forgetfulness or it could be just that one doesn’t know exactly when the 
true labour has started, but we find an unacceptable number of cases of women who don’t 
ingest the medicine and in some instances even fail to come in time for the child’s dose’.  
3.5 Discussion 
As one expert once said, primary barriers to PMTCT are not related to scientific knowledge 
but to implementation (35). The challenges faced in Zimbabwe are presented in table 13. The 
findings of this study showed that the central and most obvious barrier to PMTCT is poor 
access to ANC and delivery services due to inability to pay. These findings are 
commensurate with findings from other developing countries where inability to pay for health 
services was cited as a major deterrent to service use (36, 37 and 38). 
Given the high, regressive OOP payments exhibited in the study, policies that protect poor 
households from catastrophic payments are necessary. Although it has previously been shown 
that pre-payment mechanisms improve ability to afford health services (39), it was interesting 
to find that ownership of medical aid had no effect on affordability of services. This was to be 
expected however, considering that medical aid has not been accepted as a method of 
payment in Zimbabwe since the country experienced hyperinflationary economic instability 
and credit payments were invalidated (23). 
An increase in the wealth index was, as expected, associated with greater ability to afford 
health services. However, findings also suggested that women who were married had greater 
















Table 13 Challenges faced in accessing PMTCT in Zimbabwe 
Process  Challenges  
Attend clinic  High cost of ANC and delivery 
 Lack of transport 
 Poor provider-patient relationship 
 Poor quality of services 
 Unacceptable opening hours 
HIV counselling  Inadequate information 
 Ineffective counselling 
HIV testing  Unavailability of test kits 
Offered drugs  Drug stock-out 
 Fear breach of confidentiality 
 Limited opening hours of dispensing unit  
Take drugs  Perception of effectiveness 
 Failure to comply 
Drugs to baby  Delayed clinic visit 
Safer feeding  Mothers unsure about feeding methods 
 
It has been suggested that being married offers financial stability to the family presuming that 
there is at least one source of income to cater for household expenses (40). Consequently, 
some countries have invested in providing social grants to single-parent homes to ensure their 
financial stability, as well as providing equal opportunity jobs to increase women‘s 
participation in economic development (41 and 42).  By increasing their role in financial 
provision for the family, women would also be empowered to make important decisions in 
the home regarding health (42). Women‘s decision-making role is a subject that has received 
much attention in developing nations as it is believed that women take better care of 
themselves and their family if they have decision-making capacity (43 and 44). Decision-
making capacity was also shown to be associated with women‘s level of knowledge about 
PMTCT in this study. 
Providers also noted that most first ANC attendances were within the last trimester of 
pregnancy. This practice was because of failure to pay due to unaffordability of services 
hence resulting in delaying obtaining medical attention. Reports about this behaviour are not 
new in the literature. Studies have shown that one of the mechanisms of coping with ill-health 
among poorer populations is delaying seeking treatment (45, 46 and 47). However, the issue 
of delaying the first ANC visit has 3 potential drawbacks. Firstly, it could hamper the 

















week of pregnancy. Secondly it compromises the health of the mother and the child as routine 
monitoring and/or treatment of infections is not carried out. Finally, as identified in the study, 
late registration results in failure to verify negative HIV test results as most women will have 
no contact with the health facility by the end of the ‗window-period‘. This points to a need 
therefore, to educate women about the importance of early ANC visits in order to secure 
access to PMTCT and ensure better health. 
Communication of education and information generally constituted a major barrier to 
services. Narratives from FGD participants showed a desire for better relationships between 
health workers and patients as well as more adequate information through effective 
communication. Issues such as poor counselling, poor perception about effectiveness of 
drugs, delays in returning to the clinic with the baby, uncertainty about infant feeding 
methods and failure to comply with drug regimens are all indications of poor communication 
between the health system and patients. Although some women exhibited excellent 
knowledge about PMTCT, quite a significant number showed little or no understanding of 
PMTCT. The gap in knowledge could thus be responsible for non-utilisation of PMTCT 
services. In Dar es Salaam, Tanzania for example, women‘s lack of knowledge of the risk of 
mother-to-child transmission affected HIV test acceptance (48).  
It is therefore suggested that there is a need for improving communication between health 
workers and individuals and educating women about PMTCT. Advances towards educating 
women in South Africa have seen the implementation of a program called mothers-to-
mothers-to-be (M2M) (49). M2M offers psychosocial support to newly diagnosed mothers by 
"mentor mothers" who have practised PMTCT themselves. Mentor mothers make follow-up 
appointments and educate these mothers about their treatment and the importance of taking 
antiretroviral drugs.  
A third aspect of access that was identified in the study was the availability of services. 
Availability of ‗the right services in the right quantity at the right time‘ was found to be 
compromised in the participating facilities. The study revealed that the opening times of 
facilities were inconvenient for women. These findings are similar to those found in India 
where women under-utilised services because they could not attend the clinics at the 
suggested times as they were working in the fields or trading goods (50). Utilisation of 















Findings also showed that some women had been turned away from testing for HIV due to 
unavailability of test kits. Furthermore, lack of transport was reportedly a major barrier to 
reaching health facilities resulting in limited clinic or hospital visits. This result was similar 
to findings from Eastern Cape in South Africa where health systems failures, including lack 
of transport and resources, were blamed for women‘s failure to access PMTCT (51).  
The last and important aspect of access identified in the study was the acceptability of 
services. Women were deterred from use of health facilities where they deemed the quality of 
services to be poor and where they did not have good relations with providers. The quality of 
services has been cited in many studies internationally and regionally as affecting utilisation 
of services (51-54). In some instances individuals would rather pay more for better quality 
services than less for poor quality services (53). Findings also suggested that provider-patient 
relationships were slightly constrained and thus constituted a barrier.  
These findings point to a need to strengthen the user‘s capacity to benefit from the health 
system through establishing policies that improve financing mechanisms, provision of 
resources and provider-patient relationships.  
There were, however, limitations in this study. The major limitation was the relatively small 
sample size which may not have been representative of the population. In addition, the study 
concentrated on women already attending health services at facilities. This meant that women 
in the community who may have been totally unable to access health care were left out of the 
review. However, it is expected that the findings of the study represent challenges faced even 
by those women who were not at the facilities at the time of the study. A further limitation 
was that the participants were not selected to be HIV positive women who were in need of 
the PMTCT services. It is expected that the results would have been more representative of 
challenges faced if actual HIV positive women were interviewed and spoke out on their 
thoughts.  However, the presence of stigmatisation associated with HIV/AIDS made it 
difficult to choose respondents according to their HIV status as it would have been evident if 
some women were selected to participate while others were not. In essence, this method of 
sampling was done to protect women from facing discrimination.  
3.6 CONCLUSION 
The study conducted has shown the importance of 4 aspects of access: affordability, 














PMTCT services. The greatest of these barriers was inability to pay for services. Inability to 
pay was the main reason for low rates of ANC attendance and facility-based delivery. 
Furthermore, failure to communicate important information because of ineffective, 
inadequate and confusing counselling rendered little beneficial information to women 
resulting in them seeking (often unreliable) information elsewhere. Other barriers of 
unavailability of HIV test kits and transport to health facilities were important determinants 
of ultimate access to PMTCT. Finally quality of services in terms of hygiene standards and 
provider-patient interactions left much to be desired of the health system. 
This paper has shown that it is mainly social and practical barriers faced by prospective
clients that need to be addressed. Results suggest that key improvements would include
examining payment mechanisms that do not lead to catastrophic expenditure such as pre-
payment mechanisms, but also more importantly to ensure that facilities accept these
alternative health care payment mechanisms. In addition, while it is important to improve the
state of health facilities, establishing productive interactions between the health system and 
patients could see more women making well-informed decisions and hence utilising ANC
and PMTCT services. Finally, health workers are central to the successful implementation of
health services and hence need to be involved in the development and successful execution of
PMTCT strategies.
In conclusion, while PMTCT has been scaled up through integration into ANC services, it is 
important to address the challenges that already exist in accessing ANC services as these
inherently affect access to PMTCT. Progress will however, depend largely on greater
stewardship from the government of Zimbabwe and committed support of foreign donors and
non-governmental organisations in provision of resources.
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CHAPTER 4  
POLICY BRIEF 
THE NEED FOR PATIENT ORIENTED HEALTH SERVICES 
ADDRESSING WOMEN‘S CONCERNS REGARDING PMTCT IN ZIMBABWE 
Introduction 
HIV is the leading cause of death and disease among women of child-bearing age worldwide 
(1).  In sub-Saharan Africa up to 60% of people living with HIV are women, posing serious 
concerns for their children. In 2008, it was estimated that in low and middle income 
countries, up to 1.4 million pregnant women were living with HIV (2). Without intervention, 
as much as 40% of children born to these women would also be HIV positive and may never 
live to see their 5
th
 birthday (2). 
Whilst the drive towards the elimination of adult HIV is becoming well established in 
developing countries, that of paediatric HIV still leaves a lot to be desired. Indeed, effective 
strategies, known collectively as the prevention of mother to child transmission of HIV 
(PMTCT), have been developed to prevent paediatric HIV, but the concern remains the 
ability to provide these services to all people in need of them.  
With the dawn of the 21
st
 century came the expansion of coverage of PMTCT services in 
HIV-affected countries. PMTCT is now mainly provided through existing services such as 
antenatal care (ANC) thus incr asing access while minimising costs by making use of already 
existing resources and infrastructure. However, the significantly high HIV-specific child 
mortality rates show that the global commitment to eliminate paediatric HIV has not had 
much success (3).  
In Zimbabwe, more than a decade has elapsed since a cost-effective PMTCT package was 
first piloted and then integrated into antenatal care (ANC) (4). However, HIV-specific under-
five mortality has continued to be high suggesting a low uptake of PMTCT services (5). 
Evidence has shown that women in Zimbabwe increasingly drop out of the PMTCT 
programme at each stage from attending ANC, to HIV counselling, then testing, and finally 
administering ARVS to mother and baby (6). This is highly detrimental to any efforts 
towards combating paediatric HIV/AIDS especially considering that Zimbabwe falls within 















women (2). With increased pressure to achieve the millennium development goals (MDGs), it 
is crucial to find ways of reducing child mortality through effective targeted strategies. 
Currently Zimbabwe offers PMTCT services free of charge in facilities that provide ANC. 
PMTCT includes free HIV counselling and testing in clinics, a single dose of nevirapine for 
the mother during labour and for the baby at birth and counselling on breastfeeding options. 
However, in order for women to be introduced to the PMTCT programme, they need to 
attend ANC. While PMTCT services are free, ANC is on the other hand, not free, posing 
concerns on the affordability of the services. In addition to this, the dollarization of the 
Zimbabwean economy in 2009 may have had serious implications on access to health care 
since USD denominated user fees were pegged higher than they were when expressed in 
Zimbabwean Dollars prior to the hyperinflation (7). Each ANC visit in 2010 cost USD5 in 
urban clinics and hospitals and in rural hospitals. Rural clinics did not charge ANC fees but 
instead charged higher delivery fees (8). The average cost of delivery in rural areas was 
USD50 in hospitals and USD80 in clinics.  
This policy brief draws on research conducted in Zimbabwe to assess the barriers that women 
face in accessing PMTCT services. The findings from the study will be useful in informing 
policy that seeks to improve access to PMTCT services. By addressing the barriers that 
women face, the uptake of services could increase and hence contribute to the reduction in 
vertical transmission of HIV and thus child mortality. 
Key findings 
- As seen in figure 8, 68% of women find the cost of ANC and delivery too high. 
- Figure 9 shows that more than 8.5% of women spent more than 10% of their total 
monthly expenditure on ANC and delivery payments, suggesting challenges with the 
affordability of health care. This could possibly lead to impoverishment and prevent 














Figure 8 Main barriers to accessing PMTCT 
Figure 9 Catastrophic healthcare payments 
HH=household 
- Forty-one percent of women reported that health workers offered inadequate
information, as seen in figure 8. Inadequate information and ineffective counselling
results in a gap in knowledge about vertical transmission and PMTCT which could
potentially lead to failure to comply to PMTCT strategies. This is evidenced in
women‘s misconception that mixed feeding is better than exclusive feeding since the
child ‗sucks more of the infected milk’ in exclusive breastfeeding.
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- Figure 9 also shows that the low quality of services including the poor cleanliness of
facilities are deterrents for service use for 34% of women  while poor provider-patient
interactions are deterrents for service use for 41% of women. This means that
authorities need to consider making ANC more acceptable for women in order for
them to be able to utilise PMTCT services.
- Finally, figure 8 shows that lack of transport and shortages of drugs and other
resources prove a challenge for 26% of women which directly affects access to
PMTCT.
- Primary barriers to accessing PMTCT lie in the barriers faced in accessing ANC
services including the cost of ANC and the acceptability of ANC services. None of
the barriers expressed were linked to social or cultural issues of fear, discrimination or
perceptions about medicines. Instead the main barriers were linked to the health
system‘s failure to meet the needs of pregnant women.
Policy options 
 Remove user fees for pregnant women
- Remove maternal user fees or reduce the cost of fees since revenue can be
generated from other services that facilities provide. Removal of user fees has 
been shown to increase utilisation of and access to health services especially
among the poor (9-11). However, it requires careful consideration and gradual
phasing in depending on the state of the economy as well as the ability to continue
providing quality services in the absence of revenue generated from ANC and 
delivery.
 Increase women‘s access to reliable information
- Disseminate more information about PMTCT through media such as short
informative adverts in radios, on television and in newspapers
- Set up posters with information about PMTCT at shopping complexes and in
women‘s common meeting areas such as churches and at clinics
- Involve community leaders in disseminating information by educating them about
PMTCT and thus give them the opportunity to discuss PMTCT with their
community at their usual communal meetings















- Conduct supervisory visits to clinics more frequently to assess cleanliness and 
quality of services. These visits may be conducted by province level or district 
level health officers or managers. 
- Ensure accountability for quality of services by staff in charge of facilities by 
holding them responsible for the state of hygiene and organisation. 
- Involve health workers in decision making towards improving hygiene standards, 
organisation and general quality of services. 
 Provide training courses to health workers on issues pertaining to how to engage with 
patients in a more acceptable manner  
 Engage patients in health decision making by providing written material to 
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Appendix 1: Sample Medical Research Council of Zimbabwe (MRCZ) approved 
consent form for cross sectional survey 
MRCZ approval number: MRCZ/B/81 
REC REF UCT: 470/2009 
INFORMED CONSENT FORM
PROJECT TITLE: ASSESSING THE BARRIERS TO ACCESSING PREVENTION 
OF MOTHER TO CHILD TRANSMISSION (PMTCT) SERVICES IN 
MARONDERA, ZIMBABWE
Principal Investigator: Ms Farai Beverley Magaso
Phone numbers: +263914177441, +27728282490
What you should know about this research study:
 We give you this consent so that you may read about the purpose, risks, and benefits of this 
research study.
 Routine care is based upon the best known treatment and is provided with the main goal of
helping the individual patient.  The main goal of research studies is to gain knowledge that
may help future patients.
 We cannot promise that this research will benefit you.  Just like regular care, this research can
have risks that can be serious or minor.
 You have the right to refuse to take part, or agree to take part now and change your mind
later.
 Whatever you decide, it will not affect your regular care.
 Please review this consent form carefully.  Ask any questions before you make a decision.
















You are being asked to participate in a research study of assessing the barriers that pregnant women 
are facing in accessing the prevention of mother to child transmission (PMTCT) services.  The 
purpose of the study is to determine the problems that pregnant women may be facing in accessing 
PMTCT services designed for their use and therefore to guide implementation strategies of scaling up 
PMTCT projects You were selected as a possible participant in this study because you are a pregnant 
woman and therefore you are the population whose opinion the research is interested in.  A total of 75 
women shall participate in this study. 
PROCEDURES AND DURATION 
If you decide to participate, you will be required to answer questions in a face-to face interview with a 
trained research assistant. The interview will be based on a structured questionnaire and the 
interviewer will explain the questions in the language you prefer. It will take approximately 30 
minutes of your time. 
RISKS AND DISCOMFORTS 
You will not be exposed to any physical danger when you take part in this research. However, you 
may feel uncomfortable answering some questions and vulnerable disclosing your personal 
experiences. The interview may provoke anxiety or distress as you may be reminded of some 
difficulties you are currently facing. If at any time you feel uncomfortable answering any question, 
you may refuse to do so. There will be no negative implications of doing so.  
BENEFITS AND/OR COMPENSATION 
We cannot and do not guarantee or promise that you will receive any benefits from this study. 
However, the results of this research are set to benefit you and your community in the future as 
proposed strategies to improve PMTCT services will be built on them. The research is intended to 
benefit pregnant women particularly since the PMTCT services should be made accessible to them. 
The greatest effort will be made to ensure results are made available to you or your community but 
the primary objective is to make them known to the people who make decisions about the services 
provided. You will not be paid or compensated to take part in this study.  
CONFIDENTIALITY 
If you indicate your willingness to participate in this study by signing this document, we do not plan 
to disclose this information to any persons or agencies. Your name or identification information will 
not appear on any of the questionnaires. In addition, the consent form will in no way be linked to your 
questionnaire.  Any information that is obtained in connection with this study that can be identified 
with you will remain confidential and will be disclosed only with your permission. Study data will 
only be accessible to the principal investigator of the research. 
VOLUNTARY PARTICIPATION 
Participation in this study is entirely voluntary.  If you decide not to participate in this study, your 
decision will not affect your future relations with this clinic, its personnel, and associated hospitals or 
with the University of Cape Town.  If you decide to participate, you are free to withdraw your consent 
and to discontinue participation at any time without penalty. 
OFFER TO ANSWER QUESTIONS 
 Before you sign this form, please ask any questions on any aspect of this study that is unclear 
















 You are making a decision whether or not to participate in this study.  Your signature 
indicates that you have read and understood the information provided above, have had all your 
questions answered, and have decided to participate. 
 The date you sign this document to enroll in this study, that is, today‘s date, MUST fall 
between the dates indicated on the approval stamp affixed to each page.  These dates indicate that this 
form is valid when you enroll in the study but do not reflect how long you may participate in the 
study.  Each page of this Informed Consent Form is stamped to indicate the form‘s validity as 
approved by the MRCZ. 
 
 
    
Name of Research Participant (please print)  Date 
 
 
    AM 
Signature of Participant Time PM 
 
 
 ______________________________________   




Signature of Interpreter (where necessary)  
 YOU WILL BE GIVEN A COPY OF THIS CONSENT FORM TO KEEP. 
 
If you have any questions concerning this study or consent form beyond those answered by the 
investigator, including questions about the research, your rights as a research subject or research-
related injuries; or if you feel that you have been treated unfairly and would like to talk to someone 
other than a member of the research team, please feel free to contact the Medical Research Council of 
















Appendix 2: Sample MRCZ approved shona consent form for cross sectional 
survey 
MRCZ approval number: MRCZ/B/81 
REC REF UCT: 470/2009 
 
FOMU ROKUTENDERWA KUNERUZIVISO 
 
MUSORO: KUWONGORORA ZVIMHINGAMUPINI ZVEKUWANA RUBATSIRO 
RWEKUDZIVIRIRA KUTAPUKIRA KWECHIRWERE CHE HIV KUVANA KUBVA KUMADZIMAI 
AKAZVITAKURA (PMTCT) KUMARONDERA, ZIMBABWE 
Muongorori: Ms Farai Beverley Magaso 
Runhare: +263914177441, +27728282490 
 
Zvamunofanirwa kuziva pamusoro petsvagurudzo iri: 
 Tinokupayi fomu iri kukuzivisai chinangwa, njodzi nemubairo 
wetsvagurudzo iri. 
 Rubatsiro rwehurwere rwamunowana mazuvaose runopiwa riinechinangwa 
chokubatsira murweri. Chinangwa chetsvagurudzo ndechekuwana ruzivo 
runobatsira pavarwere vamangwana. 
 Hativimbisi kuti tsvagurudzo iri richakubatsirai.  Serubatsiro rehurwere 
rwemazuva ose tsvagurudzo inogona kuva nenjodzi yakayipisa kanashoma. 
 Munemaruramiro ekuramba kubatirana mutsvagurudzo kanakubvuma 
kubatirana parizvino asi muchizogona kusandura pfungwa pamberi. 
 Chero zvamunenge mafunga hazvikanganise rubatsiro rwenyu rwepakiriniki 
rwemazuva ose. 
 Nyatsoongororai fomu iri mugozobvundza mibvunzo yamunenge muinayo 
musati maita sarudzo 




Murikukumbirwa kubatirana netsvagurudzo rokuwongorora zvimhingamupini zvekuwana rubatsiro 
rwekudzivirira kutapukira kwechirwere che HIV kuvana kubva kumadzimai akazvitakura. Chinangwa 















rubatsiro rwekudzivirira kutapukira kwechirwere che HIV kuvana kubva kumadzimai akazvitakura 
zvichizobatsira kutungamira mukushandiswa kwemazano ekuwedzera zvirongwa zwePMTCT.  
Zvinogoneka kuti mubatirane mutsvagurudzo iri nokuti murimudzimai akazvitakura saka ndimi 
muneruzivo rurinani patsvagurudzo redu.  Tsvagurudzo iri richabvunzurudza madzimai akazvitaruka 
anopfura 75. 
ZVICHAITWA NENGUVA YAZVICHATORA 
Kana mukafunga kutora sarudzo yokubatirana patsvagurudzo iyi munotarisirwa kupindura 
mibvunzo yamuchabvunzwa makatarisana nemubatsiri wetsvagurudzo akadzidziswa. 
Bvunzurudzo ichange yakanangiswa nemibvunzo yakarongwa uye mubvunzi 
achakutsanangurirai mibvunzo nemutauro wamunonzwisisa. Zvinogona kutora maminetsi 
angasvika makumi matatu enguva yenyu. 
NJODZI 
Hamuzopinzwi munjodzi kanamabatirana netsvagurudzo iyi. Asi mungangosanzwa 
kugadzikana pakupindura mimwe mibvunzo nokuburitsa pachena zvamakapfura nazvo 
muhupenyu. Bvunziridzo inogona kukonzera kusagadzikana kana kunetsekana pamusoro 
pekurangaridzwa zvimwe zvezvinhu zvakaoma zvamurikupfura nemazviri. Kana 
mukangonzwa kusagadzikana mukupindura mimwe mibvunzo munogona kuramba 
kuipindura. Panenge pasina chakaipa mukuramba.  
 
MIBAIRO NEMIBHADARO 
Hatisimbisi kana kuvimbisa kuti muchawana mibairo mutsvagurudzo iyi. 
Asi zvichabuda mutsvagurudzo iyi zvichabetsera imi kana vemunharaunda muneramangwana 
sezvo mazano ekuvandudza rubatsiro rwePMTCT  achange achibva pano. Tsvagurudzo iyi 
yakanangana nokubatsira madzimai akazvitakura sezvo rubatsiro rwePMTCT ruchifanirwa 
kuwanikwa navo. Simba rose richaiswa mukuyedza kukuzivisai nevenharaunda yenyu 
zvinenge zvabuda mutsvagurudzo iyi, asi chinangwa chikuru kuzivisa vanhu vanoita sarudzo 
pamusoro perubatsiro rwamunopiwa. 
Rubatsiro rwamunenge mapa patsvagurudzo iyi harubhadharwi. 
KUCHENGETEDZWA KWEZVAKAVANZIKA 
Mukabvuma kubatirana netsvagurudzo iyi nokusayina tsamba iyi, hatizoisi pachena umbowo 
hwenyu kana kuzivisa ani nani. Zita renyu kana umbowo hwekuti ndimi ani hazwizoiswi 
pamapepa emibvunzo. Pamusoro paizvozvo bepa rino harisikuzombobatanidzwa nebepa 
remibvunzo.  Umbowo hwese unogona kuwanikwa mutsvagiridzo iyi unogona kuzivisa kuti 
ndimi ani uchachengetedzwa wakavanzikwa uyezve uchizogona kuziviswa kana matendera 
chete.  Umbowo wetsvagurudzo iyi uchange uchingozikanwa nemuongorori wetsvagurudzo 
chete. 
KUBATIRANA KUNESARUDZO RWAKASUNUNGUKA 
Kubatirana netsvagurudzo iyi kunesarudzo rwakasununguka. Mukange mafunga 















nevashandi vayo nezvipataro zvinodyidzana nayo kana neUnivhesiti ye Cape Town.  Kana 
mukasarudza kubatirana netsvagurudzo iyi makasununguka kumisa kubatirana nayo 
nenguva ipi zvayo pasina mirango. 
MVUMO YEKUBVUNZA MIBVUNZO 
Musati masayina fomu munotenderwa kubvunza mibvunzo yamuyinenge muyinayo 
pamusoro pechipi nechipi chetsvagurudzo iyi zvingadayi zvisina kujeka kwamuri. Munogona 
kutora nguva yamunoda kufunga nezvazvo. 
MVUMO 
Murikuita sarudzo rokubatirana kana kusabatirana netsvagurudzo iyi. Kusayinira kwenyu 
chiratidzo chekuti maverenga mukanzwisisa umbowo wamapiwa, mukapindurwa mibvunzo 
yenyu yose, uye mukabvuma kubatirana netsvagurudzo iyi. 
Musi wamuchasayina mapepa ano kubatirina netsvagurudzo ino, zvichireva musi wanhasi 
UNOFANIRWA  kunge uripakati pemazuva anoratidzwa pachitamba chekutenderwa 
kwetsvagurudzo iyi chiripamapepa ano.  Mazuva awa anoratidza kuti mapepa ano 
achirikushanda musi wamunobatirana netsvagurudzo iri asi haaratidzi nguva yamuchatora 
muchibatirana netsvagurudzo. Rimwe nerimwe bepa remapepa ano efomu rekutenderwa 
rineruziviso rakadhindwa nechitamba kuratidza kuti fomu richirikushanda maererano 
nemvumo yeMedical Research Council ye Zimbabwe (MRCZ). 
    
Zita renyu  Zuva 
    AM 
Siginecha yenyu  Nguva                 PM 
____________________________________  
Siginecha yavakatarisa Siginecha yemushandi apiwa mvumo 
 
Siginecha yemududziri   
MUCHAPIWA BEPA RIRIMUFANANIDZO WEIRI KUTI MUZVICHENGETERE 
Kana muyinemibvunzo maererano netsvagurudzo ino kana mapepa ano inopfurira 
iyoyamapindurwa nemuongorori inosanganisa mibvunzo yezvetsvagurudzo ino, maruramiro 
enyu semubatirani wetsvagurudzo iri, kana kukwara mutsvagurudzo iyi, kana kuti 
muchinzwa sekunge musina kubatiwa zvakanaka huye muchida kutaura nomunhu asiri 
mushandi wetsvagurudzo iyi, sunungukayi kuzivisa veMRCZ. Runhare rwavo runoti 04 















Appendix 3: Survey Questionnaire 
 
ASSESSING THE BARRIERS TO ACCESSING PREVENTION OF MOTHER TO CHILD TRANSMISSION 
(PMTCT) SERVICES IN MARONDERA, ZIMBABWE 
 
DATE OF INTERVIEW                                                                                                        ........./........../........... 
 
INTERVIEWEE NUMBER                                                                                                      place sticker here 
 
FACILITY NAME…………………………………………………………………………………………………………………………………… 
NAME OF INTERVIEWER…………………………………………………………………………………………………………………….. 
 
SECTION A: SOCIO-ECONOMIC AND DEMOGRAPHIC CHARACTERISTICS 
   
1. How old are you?  
 











































6. If employed, what is your occupation, that is, what kind of 
work do you mainly do? 
Farmer………………………..………...1 
Trader…………………………..……….2 
Employed in the formal 
sector……………………………….……3 
No response...........................97 





8.  How many people live in your household? By ‘household’ I 
mean people that you live with and share food with. 
 
9. Who is the head of your household? By this, I mean, who 
is the person who usually makes the important decisions 



























10. Is the head of the household employed? Yes…….......................................1 
No…….......................................0 
No response...........................97 















SECTION B: KNOWLEDGE ABOUT PMTCT 






























16. If yes, please indicate whether or not it is spread at any of 
the following stages using yes=1, no=0, don’t know=99 
 
During pregnancy                                                                                                                                                   
Delivery 
Breastfeeding 
During daily activities e.g. bathing, hugging  
 
 
Yes                No          Don’t know   
1                     0             99 
1                     0             99 
1                     0             99 
1                     0             99 
17. Is there anything a pregnant woman can do to avoid or 
reduce chances of spreading HIV to her child? 
 
Yes…………………………………..……1 
No…………………………….0           20      
Don’t know………………99         20 
No response.........................97 
18. Are there any special medications that a doctor or a 
nurse can give to a woman infected with HIV to reduce 







19. If yes, do you think prevention of mother to child 






















transmission from a mother to her child? By replacement 
feeding, I mean feeding your baby formula milk or other 




21. Can delivering by Caesarean section, that is delivering 
your baby through surgery rather than normal delivery, 
also reduce the risk of HIV transmission from a mother to 






22. Can mixed feeding, that is breastfeeding and feeding your 
baby other food or formula milk at the same time, also 






23. Where did you find out about PMTCT? At a health facility……………….…1 
From friends/relatives……….….2 





SECTION C: PRACTICES, ATTITUDES TOWARDS PMTCT AND ACCEPTABILITY OF PMTCT SERVICES 
24. Who usually makes decisions about health care for you? Self………………………………………….1 
Partner……………………………..…....2 






















 No response..............................97 
26. As part of your antenatal care visits during this pregnancy 







27. As part of your antenatal care visits during this pregnancy 
were you ever told about things to do to prevent 







28. As part of your antenatal care visits during this pregnancy 







29. Does your culture allow you to use medication? Yes………………………………………...…1 
No…………………………….…………......0 
No response................................97 
30. Does your religion allow you to use medication? Yes………………………………....…………1 
No……………………………....……………0 
No response................................97 
31. Have you ever been offered counselling for HIV during 


























33.  If no, why weren’t you satisfied? Indicate with yes=1, 
no=0,  
 
The language used was inappropriate 
The manner of communication was inappropriate 
Not enough information was given 
The environment was not good enough 
Other reason (specify) 
 
 
                                                                     
Yes                                 No               
1                                      0                      
1                                      0                      
1                                      0                      
1                                      0                      
1                                      0                      










36. If you were not tested, what was your reason for not 
testing (can be more than one reason)? Please indicate 
with yes=1, no=0 
                                                                                                           
Can’t afford                                                                                    
Don’t know where to go 
Testing site difficult to get to 
Scared of test results 
Fatalistic/nothing can be done 
No personal benefit 
Confidentiality may be breached 
No perceived risk of HIV                                                                   
Scared that people in the community may judge you 
 
 
            
                                                               
                 















Scared that the health workers may judge you 
Other(specify) 
 
37. If your results were to show that you are HIV positive, 





38. If no or don’t know, what would your reason be for  
Potentially not telling him? 
  
Fear of violence 
Fear of being abandoned 





Yes                      No 
1                          0 
1                          0 
1                          0 
1                          0 
 
39. Do you believe HIV positive women are treated unfairly 







Many different factors can prevent women from getting 
medical advice or treatment for themselves. When you 
are sick and want to get medical advice or treatment, is 
each of the following a big problem or not?  
 
Getting permission to go? 
 
Getting money needed for treatment?  
 
The distance to the health facility? 
 
Having to take transport? 
 
Not wanting to go alone? 
 






Yes                               No 
 
 
                                   
                                   
                                   
                                   
                                   
                                   
                                   















Concern that there may not be any health provider?  
 
Concern that there may not be drugs available? 
Other  
(specify) 
41. Health providers are trained to assist you in any problems 
or with advice during your pregnancy. For the next 
questions please indicate to what extent they assist you 
with the following using 1=always, 2=most of the time, 
3=sometimes, 4=never. 
a. Education and counselling about pregnancy 
and/or PMTCT 
b. Advice on any medical issues 
c. Identifying and monitoring any complications in 
your pregnancy 
 
42. Would you deliver at this facility? Yes…............................................1 
No….............................................0 
No response...............................97 




Don’t trust facility 
Poor quality services 
Not necessary 





Yes                   No    
1                       0 
1                      0 
1                      0 
1                      0 
1                      0 
1                      0 
1                      0 



















SECTION D: AVAILABILITY AND AFFORDABILITY 
50. If you were to walk here from your home, how long 
would it take you? 
 
.............hrs...............minutes 
45. How do you find the staff relationship with patients here? Good………………………………………....1 
Fair...………………………………………….2 
Bad................................................3 










48. What would your main reason be for breastfeeding? It is culturally the most acceptable 
way of feeding........…………………....1 
It is the best way to feed a baby….2 
Unavailability of formula milk........3 
Un-affordability of formula milk....4 
Unavailability of safe water for 
formula feeding.............................5 




No response..............................   97 




















51. Do you require transport to get here? Yes………………………………………………1 
No……………………………………………….0 
No response..................................97 
52. If yes is the cost of transport too high? Yes……………………………………………...1 
No……………………………………………....0 
No response..................................97 




54. How long do you normally wait before being served?              ............hrs................minutes 
55. Do you find the waiting time too long? Yes .................................................1 
No...................................................0 
No response...................................97 

































No……………………………………0          62 
No response...................................97 
61. Do you find it difficult to pay for these services? Yes………………………………………………1 
No……………………………………………….0 
No response..................................97 
62. If no why not? Free services….................................1 
Medical aid pays…...........................2 
Exempted from paying....................3 
Other (specify).................................4 
____________________________ 
63. During your pregnancy did you have to borrow 
money to pay for healthcare? 
Yes…………………………………………………1 
No…………………………………0         65 
No response...................................97 
64. If yes how much money did you borrow? US$ 
65. During your pregnancy, did you have to sell personal 









Someone to take over your tasks while you are here 
including childcare 
Food during visit 


















67. Do you find the total cost of seeking treatment too 
high, in other words, did you find it easy or difficult to 
incur all these expenses? 
Easy………………………..…………………….1 
Difficult…………………………………………2 
Neither easy nor difficult……………..3 
68. Which of the following best describes the type of 
house you live in? 
House or brick structure on a 
separate stand or yard or on farm…1 
  Traditional dwelling/hut/structure 
made of traditional materials………..2 
  Dwelling/house/flat/room in 
backyard……………………………………….3 
  Informal dwelling/shack IN the 
backyard of a formal house…………..4 
  Informal dwelling/shack NOT in 
backyard e.g. in an informal/squatter 
settlement or on 
farm………………………………………………5 
  Room on a shared property…………..6 
  Worker’s hostel…………………………….7 
  Other…………………………………………….8 
  If other, specify 
 
69. What is the main material of your house’s walls? Bricks & plaster/finished.................1 
  Bare brick/cement block.................2 
  Corrugated iron/zinc........................3 
  Wood...............................................4 
  Plastic..............................................5 
  Cardboard.......................................6 
  Mixture of mud and cement...........7 
  Wattle and daub..............................8 















  Thatching........................................10 
  Other..............................................11 
  If other, specify 
 
70. What is the main material of your house’s roof? Tiles .................................................1 
  Corrugated iron/zinc........................2 
  Thatching.........................................3 
  Asbestos……………………………………….4 
  Plastic...............................................5 
  Cardboard........................................6 
  Other................................................7 
  If other, specify 
71. What is the main source of drinking water for 
members of your household? 
Piped (tap) water in dwelling...........1 
  Piped (tap) water on site or in 
yard..............................................2 
  Borehole on site...............................3 
  Rain water tank on site....................4 
  Neighbour’s tap...............................5 
  Public/communal tap (either free or 
paid).................................................6 
  Water carrier/tanker.......................7 
  Borehole off site/communal...........8 
  Flowing water/stream/river............9 
  Well................................................10 
  Other..............................................11 
















72. What type of toilet does your household have? Flush toilet (connected to sewer)....1 
  Flush toilet (with septic tank)...........2 
  Pit latrine with ventilation pipe.......3 
  Pit latrine without ventilation pipe..4 
  Bucket toilet....................................5 
  No facility/bush/field......................6 
  Other...............................................7 
  If other, specify 
 
73. What is the main source of energy for cooking in your 
household? 
 
Electricity from mains......................1 
  Electricity from generator...............2 
  Gas...................................................3 
  Paraffin............................................4 
  Wood...............................................5 
  Coal..................................................6 
  Animal dung....................................7 
  Solar energy....................................8 
  Other...............................................9 
  If other, specify 
 
74. Does your household own cattle, livestock or 
chickens? 
Yes....................................................1 
No........................................0         79 

















76. How many goats does the household own? _____________goats 
None...............................................0 
Don’t know...................................99 
77. How many chickens does the household own? ______________chickens 
None................................................0 
Don’t know....................................99 
78. Does the household own any other animals? 
(specify) 




79. Does your household own a car? Yes.................................................1 
No..................................................0 
80. Does your household own a truck? Yes..................................................1 
No...................................................0 
81. Does your household own a bicycle? Yes.................................................1 
No..................................................0 
82. Do you have anything else you would like to say 

























Appendix 4: Shona Questionnaire 
Bepa rezvemibvunzo wetsvagurudzo 
KUWONGORORA ZVIMHINGAMUPINI ZVEKUWANA RUBATSIRO RWEKUDZIVIRIRA 
KUTAPUKIRA KWECHIRWERE CHE HIV KUVANA KUBVA KUMADZIMAI AKAZVITAKURA 
(PMTCT) KUMARONDERA, ZIMBABWE 
 
Zuva                                                                                                                                   ........./........../........... 
 
Ndewechingani arikubvunzwa                                                                                   
 
Zita rechipatara…………………………………………………………………………………………………………………………………… 
Zita re anobvunza mibvunzo………………………………………….....……………………………………………………………….. 
 
Chikamu chekutanga: chimiro pakati pevanhu nehupfumi hwenyu nezvamuri 
   
1. Munemakore mangani okuzvarwa?  
 















































8. Mumba mamunogara munavanhu vangani ndichireva 
ivo vamunodya navo uye muchigara mose? 




















sekuru kana mbuya…..............……..7 





10. Musoro wemumba menyu anoshanda here? hongu............................................1 
kwete.............................................0 
hapana mhinduro........................97 














Chikamu chepiri:ruzivo rezvePMTCT 



















anechirwere cheHIV? kwete.......................................0 
hapana mhinduro...................97 






16. Kana mati hongu, ratidzai kuti inobatira kana kuti 




mukugezesa mwana kana kumubata 
hongu  kwete   hamuziyi  
1   0    99 
1   0    99 
1   0    99 
1  0    99 
17. Panezvingaitwe nomudzimai akazvitakura kudzivirira 
kutapukira kweHIV kumwana wake kubva kwaari here?
hongu…………………..…............…1 
kwete…………........…….0    20 
hamuziyi……......………99   20 
hapana mhinduro..................97 
18. Panemushonga ungapiwe nachiremba kunemudzimai
akazvitakura aneHIV kuti adzivirire kutapukira









20. Kusayamwisa mwana kunogona kudzikisira chiyero 



















21. Kubatsirwa nekuoparetwa kungabatsire kudzikisira 







22. Kuyamwisa mwana muchizanganisa nokumupa chimwe 
chikafu kana mukaka wemabhodhoro kunodzikisira 






23. Iyo PMTCT makanzwa nezvayo kubva kunani? Kuchipatara..........………...…….…1 
Kubva kuhama kana shamwari..2 







Chikamu chechitatu: zviito zvenyu, maonero nekugamuchirika kwerubatsiro rwePMTCT  
24. Ndiyani anoronga nezveutano hwenyu? Imi pachenyu...…………………………1 
Murume wenyu...………………..…..2 
Ruviri rwenyu……..........…..…….….3 

























26. Muzvidzidziso zvekuchipatara chemadzimai akazvitakura 
makamboudzwa nezvekutapukira kweutachiwana weHIV 





27. Muzvidzidziso zvekuchipatara chemadzimai akazvitakura 
makambopiwa mazano ekudzivirira kutapukira 





28. Muzvidzidziso zvekuchipatara chemadzimai akazvitakura 













30. Chitendero chenyu chinobvuma kuti mushandise 




31. Makambopiwa mazano neyambiro yewutachiwana 
























33.  Kana mati kwete, sei musina kugutsikana?  
 
 
mutauro wakashandiswa wanga usinganzwisisiki 
matauriro acho anga asina kunaka 
pakange pasina umbowo wakakwana 




                                                                     
hongu                      kwete               
1                                      0                      
1                                      0                      
1                                      0                      
1                                      0                      
1                                      0                      
34. Makambovhenekwa kuti munechirwere cheHIV here 










36. Kana musina kuvhenekwa chinangwa chenyu 
chekusavhenekwa chakange chiri cheyi?  
                                                                                                           
kutadza kukwanisa kubhadara                                                                  
kusaziva kwekuenda 
kunovhenekwa kwacho kunonetsa kusvika 
kutya zvaizobudamo 
hapana zvingaitwe nezvaizobudamo 
hapana rubatsiro kwandiri 
zvinozoziviswa vamwe 
hapana nzira yandingave ndakachibatira chirwere cheHIV                                                                   
        
 















kutya kuzosvoropodzwa nevemunharaunda 
kutya kusvoropodzwa nevanoshanda nezveutano  
zvimwe (motsanangura) 
 
37. Kurikuti zvinenge zvabuka muvheneko zvinoratidza kuti 















hongu                    kwete 
1                          0 
1                          0 
1                          0 
1                          0 
 
39. Munofunga kuti vadzimai vanowanikwa vaineHIV 







Zvakawanda zvikonzero zvinotadzisa vanhukadzi kuwana 
mazano ezvekurapiwa kana kurapiwa kwacho. Kana 
muchirwara muchida mazano ezvekurapiwa kana 
kurapiwa, panezvinotevera, pangaita dambudziko hombe 
kana kuti kwete?  
 
Kuwana mvumo yokuenda kuchipatara? 
 
Kuwana mari inodikwa pakurapiwa?  
 


























Kubatikana kuti munozoshaya munhu wechikadzi 
anokubatsirai kuchipatara? 
 
Kubatikana kuti munozoshaya anokubatsirai kuchipatara? 
 
kubatikana kuti munozoshaya mishonga inokurapayi? 
zvimwe (motsanangura) 
 
41. Vanoshanda nezveutano vakadzidziswa kukubatsirai 
mumatambudziko  kana kukupayi mazano panguva 
yekuzvitakura. Ratidzai kuti vanokubatsirai zvakadii 
munezvinotevera muchishandisa izvi: 1=nguva dzose, 
2=nguva zhinji, 3=dzimwe nguva, 4= havabatsiri zvachose 
a. dzidziso neyambiro  pamusoro pekuva 
nepamuviri pamwechete nezvePMTCT 
b. Mazano anezvekuita nezveutano 
c. mukutarisa nekuongorora zvigozhero 
zvepamuviri 
 
42. Mungabatsirwa pachipatara chino? hongu.........................................1 
kwete..........................................0 
hapana mhinduro......................97 





hamuvimbi nechipatara chino 
rubatsiro rwepano haruna kunyatsonaka 
hazvina zvazvinobatsira  






hongu             kwete   
1                       0 
1                      0 
1                      0 
1                      0 
1                      0 
1                      0 
1                      0 


























47. Kana mati hongu, munonga muchizomuyamwisa sei? Kuyamwisa chete …..........…………..1
Kuyamwisa nekumupa chimwe 
chikafu pamwechete……….....……..2 
Hapana mhinduro........................97
48. Nemhaka yei muchiti mungape mwana mukaka 
wepazamu?
Ndiyo tsika yechivanhu chenyu.....1 
Ndiyo nzira yakanakisa 
yokuchengeta nayo mwana…........2 
Kushayikwa kwemukaka yevana 
wemumagaba................................3 
Hamukwanisi  kubhadharira  
mukaka wevana wemumagaba 
nekuda kwemutengo yacho..........4 
Kushaikwa kwemvura yakachena 
yekugadzira mukaka 
wemwana......................................5 




















Chikamu chechina: kuwanika nekugona kubhadhara 
50. Zvingakutorerei nguva yakareba zvakadii 
kufamba kubva kumba kwenyu kusvika pano? 
 
.............hrs...............minutes 
51. Munoda chifambiso here kusvika pano? hongu………………..............………………………1 
kwete……………………………..........…………….0 
hapana mhinduro...................................97 
52. Kana mati hongu, mubhadharo wechifambiso 








54. Munochimira nguva yakareba zvakadii kuti 
mubatsirwe pamunouya pano? 
              
............hrs................minutes 
55. Nguva iyi rakarebesa here kwamuri? Hongu....................................................1 
Kwete......................................................0 
Hapana mhinduro..................................97 





57. Rubatsiro rwePMTCT runowanikwa pachipatara 
chino here? 
hongu………………………..............................1 
49.  Ingadayi kuchinzi munofanirwa kutora mushonga 






























60. Munobhadhariswa here kupiwa rubatsiro pano? hongu…..…………………………….............…….1            
kwete…………………..........……………0          62 
ha ana mhinduro..................................97 
61. Izvi zvinokuremerai here? hongu………………………………...............……1 
kwete…………………………………………..........0 
hapana mhinduro..................................97 
62. Kana mati hazvikuremerei sei muchidaro? Rubatsiro rwacho harubhadharwhi........1 







63. Panguva yekuzvitakura makambokwereta mari 
yekurapiswa? 
hongu……………………..........……………………1 
kwete…………………………….............0         65 
hapana mhinduro.................................97 















65. Panguva yekuzvitakura, makambotengesa 





66. Mukuuya kwamaita pano nhasimabhadhara mari 
yezvinotevera: 
Chifambiso 
Mari yekuti mupiwe rubatsiro 
Mushonga 
Munhu achasara achiita basa ramanga 
muchifanirwa kuita musati mauya kuchipatara 
pamwechete nekuchengeta vana 
chikafu chamadya panguva yamanga muri pano 
pachipatara 







67. Munoona zvichirema here kana kureruka 




68. Imba yamunogara mungati imba yakaita sei? Imba yezvitinha yakamira yoga 
muyhadhi................................................1 
Imba  sedzekumusha..............................2 
Imba yekuseri.........................................3 
Imba yemapurasitiki yekuseri ...............4 
Imba yemapurasitiki pazere dzimwe.....5 





































71. Mvura yamunonwa mumba menyu inobva payi? Mupombi................................................1 
Mupombi yemuyadhi.............................2 
Mugomba muyadhi rinoshanda 
nemagetsi...............................................3 

















Papombi imwe chete yevanhu vose 
vemunzvimbo ino..................................6 
Mutanga................................................7 






72. Chimbuzi chemba yenyu chakaita sei? Itoyireti iinemvura...................................1 
Igomba rakacherwa.................................2 
Tinoshandisa mabhakidhi........................3 




73. Munoshandisa magetsi rudziyi pakubika mumba 
yenyu? 
Magetsi enyika.........................................1 

























75. Kanamati hongu, munemombe dzingani? 
76. Munembudzi ngani? 
77. Munehuku ngani? 
78. Kana muyinezvimwe zvifuyo motsanangura 
79. Pamba penyu munemotokari here? Hongu......................................................1 
Kwete......................................................0 
Hapana mhinduro..................................97 
80. Paimba  yenyu munetiraki here? Hongu......................................................1 
Kwete......................................................0
Hapana mhinduro..................................97
81. Paimba yenyu munebha’sikoro here? Hongu.....................................................1
Kwete.....................................................0
Hapana mhinduro.................................97 
82. Kana paine zvimwe zvamunoda kutaura kana
kubvunza, sunungukai kubvunza kana kutaura 
henyu.















Appendix 5: Sample MRCZ approved consent form for Focus Group Discussion 
participants 
 
MRCZ approval number: MRCZ/B/81 
REC REF UCT: 470/2009 
 
PROJECT TITLE: ASSESSING THE BARRIERS TO ACCESSING PREVENTION 
OF MOTHER TO CHILD TRANSMISSION (PMTCT) SERVICES IN 
MARONDERA, ZIMBABWE 
 
Principal Investigator: Ms Farai Beverley Magaso 
Phone numbers: +263914177441, +27728282490 
 
What you should know about this research study: 
 
 We give you this consent so that you may read about the purpose, risks, and benefits of this 
research study. 
 
 Routine care is based upon the best known treatment and is provided with the main goal of 
helping the individual patient.  The main goal of research studies is to gain knowledge that 
may help future patients. 
 
 We cannot promise that this research will benefit you.  Just like regular care, this research can 
have risks that can be serious or minor. 
 
 You have the right to refuse to take part, or agree to take part now and change your mind 
later. 
 
 Whatever you decide, it will not affect your regular care. 
 
 Please review this consent form carefully.  Ask any questions before you make a decision. 
 
 Your participation is voluntary. 
 
PURPOSE 
You are being asked to participate in a research study of assessing the barriers that pregnant women 
are facing in accessing the prevention of mother to child transmission (PMTCT) services.  The 
purpose of the study is to determine the problems that pregnant women may be facing in accessing 
PMTCT services designed for their use and therefore to guide implementation strategies of scaling up 
PMTCT projects. You were selected as a possible participant in this study because you are a pregnant 
woman and therefore you are the population whose opinion the research is interested in.  A total of 
about 20 women will participate in 2 group discussions. 
 















If you decide to participate, you will be required to share your knowledge, ideas and concerns in a 
discussion with other pregnant women such as yourself. The discussion will be based on a semi-
structured questionnaire and will take approximately 1 hour of your time. 
RISKS AND DISCOMFORTS 
You will not be exposed to any physical danger when you take part in this research. However, you 
may feel uncomfortable answering some questions and vulnerable disclosing your personal 
experiences. The discussion may provoke anxiety or distress as you may be reminded of some 
difficulties you are currently facing. There will be no negative implications of not participating in the 
discussion at any point in time. 
 
BENEFITS AND/OR COMPENSATION 
We cannot and do not guarantee or promise that you will receive any benefits from this study. 
However, the results of this research are set to benefit you and your community in the future as 
proposed strategies to improve PMTCT services will be built on them. The research is intended to 
benefit pregnant women particularly since the PMTCT services should be made accessible to them. 
The greatest effort will be made to ensure results are made available to you or your community but 
the primary objective is to make them known to the people who make decisions about the services 
provided. 
You will not be paid or compensated to take part in this study. 
CONFIDENTIALITY 
If you indicate your willingness to participate in this study by signing this document, we do not plan 
to disclose this information to any persons or agencies. Any information that is obtained in connection 
with this study that can be identified with you will remain confidential and will be disclosed only with 
your permission. Study data will only be accessible to the principal investigator of the research. 
VOLUNTARY PARTICIPATION 
Participation in this study is entirely voluntary.  If you decide not to participate in this study, your 
decision will not affect your future relations with this clinic, its personnel, and associated hospitals or 
with the University of Cape Town.  If you decide to participate, you are free to withdraw your consent 
and to discontinue participation at any time without penalty. 
OFFER TO ANSWER QUESTIONS 
 Before you sign this form, please ask any questions on any aspect of this study that is unclear 
to you.  You may take as much time as necessary to think it over. 
AUTHORIZATION 
 You are making a decision whether or not to participate in this study.  Your signature 
indicates that you have read and understood the information provided above, have had all your 
















 The date you sign this document to enroll in this study, that is, today‘s date, MUST fall 
between the dates indicated on the approval stamp affixed to each page.  These dates indicate that this 
form is valid when you enroll in the study but do not reflect how long you may participate in the 
study.  Each page of this Informed Consent Form is stamped to indicate the form‘s validity as 
approved by the MRCZ. 
 
 
    
Name of Research Participant (please print)  Date 
 
 
    AM 
Signature of Participant Time PM 
 
 
 ______________________________________   




Signature of Interpreter (where necessary) 
 
  
 YOU WILL BE GIVEN A COPY OF THIS CONSENT FORM TO KEEP. 
If you have any questions concerning this study or consent form beyond those answered by the 
investigator, including questions about the research, your rights as a research subject or research-
related injuries; or if you feel that you have been treated unfairly and would like to talk to someone 
other than a member of the research team, please feel free to contact the Medical Research Council of 

















Appendix 6: Focus Group Discussion guide 
What are your ages? 
Where do you stay? 
Where do women go for ANC and delivery in your areas? (If care sought, place and why there) 
Do you have to pay for these health services? 
- Services paid for 
- Amount paid, other expenses encountered 
What difficulties have you experienced in your search for health care? 
-Concerns raised 
   -Expectations women have 
 What do other people say about services at this facility? 
- Their experience of ANC 
- Experience with staff 
- What is good or bad 
- How services can be improved 
 Do a lot of people use ANC services these days 
- Reasons for use/non-use 
- Where else do people go and why do they go there 
 Do you get all the information you need here regarding pregnancy, delivery, HIV, PMTCT? 
 What have you heard or been taught about PMTCT? 
- Knowledge about HIV transmission from mother to child 
- Knowledge about ways of preventing HIV transmission from mother to child 
What in your opinion is the best way of feeding your baby if HIV positive? 
Do you think there are any problems within achieving the goals of PMTCT here? 
- Any instances where PMTCT has failed 
- Areas where more attention is needed 














Appendix 7: Sample MRCZ approved consent form for health providers 
MRCZ approval number: MRCZ/B/81 
REC REF UCT: 470/2009 
PROJECT TITLE: ASSESSING THE BARRIERS TO ACCESSING PREVENTION 
OF MOTHER TO CHILD TRANSMISSION (PMTCT) SERVICES IN 
MARONDERA, ZIMBABWE 
Principal Investigator: Ms Farai Beverley Magaso 
Phone numbers: +263914177441, +27728282490 
What you should know about this research study: 
 We give you this consent so that you may read about the purpose, risks, and benefits of this 
research study.
 Routine care is based upon the best known treatment and is provided with the main goal of
helping the individual patient.  The main goal of research studies is to gain knowledge that
may help future patients.
 We cannot promise that this research will benefit you.  Just like regular care, this research can 
have risks that can be serious or minor.
 You have the right to refuse to take part, or agree to take part now and change your mind 
later.
 Whatever you decide, it will not affect your regular care.
 Your participation is voluntary.
PURPOSE 
You are being asked to participate in a research study of assessing the barriers that pregnant women
are facing in accessing the prevention of mother to child transmission (PMTCT) services. The
purpose of the study is to determine the problems that pregnant women may be facing in accessing
PMTCT services designed for their use and therefore to guide implementation strategies of scaling up
PMTCT projects. You as the health provider were selected to participate as you may have a better
understanding of the problems that pregnant women are faced with.
PROCEDURES AND DURATION 
If you decide to participate, you will be required to answer questions in a short interview with a 
trained research assistant. The interview will be based on a semi- structured questionnaire and will 
take approximately 20 minutes of your time. 















You will not be exposed to any physical danger when you take part in this research. If at any time you 
feel uncomfortable answering any question, you may refuse to do so. There will be no negative 
implications of doing so.  
BENEFITS AND/OR COMPENSATION 
We cannot and do not guarantee or promise that you will receive any benefits from this study. 
However, the results of this research are intended to benefit pregnant women particularly since the 
PMTCT services should be made accessible to them. The greatest effort will be made to ensure results 
are made available to you but the primary objective is to make them known to the people who make 
decisions about the services provided. 
You will not be paid or compensated to take part in this study.  
CONFIDENTIALITY 
If you indicate your willingness to participate in this study by signing this document, we do not plan 
to disclose this information to any persons or agencies. Any information that is obtained in connection 
with this study that can be identified with you will remain confidential and will be disclosed only with 
your permission. Study data will only be accessible to the principal investigator of the research. 
VOLUNTARY PARTICIPATION 
Participation in this study is entirely voluntary.  If you decide not to participate in this study, your 
decision will not affect your future relations with this clinic, its personnel, and associated hospitals or 
with the University of Cape Town.  If you decide to participate, you are free to withdraw your consent 
and to discontinue participation at any time without penalty. 
OFFER TO ANSWER QUESTIONS 
 Before you sign this form, please ask any questions on any aspect of this study that is unclear 
to you.  You may take as much time as necessary to think it over. 
 
AUTHORIZATION 
 You are making a decision whether or not to participate in this study.  Your signature 
indicates that you have read and understood the information provided above, have had all your 
questions answered, and have decided to participate. 
 The date you sign this document to enroll in this study, that is, today‘s date, MUST fall 
between the dates indicated on the approval stamp affixed to each page.  These dates indicate that this 
form is valid when you enroll in the study but do not reflect how long you may participate in the 
study.  Each page of this Informed Consent Form is stamped to indicate the form‘s validity as 
approved by the MRCZ. 
 
    
















    AM 
Signature of Participant Time PM 
 
 ______________________________________   




Signature of Interpreter (where necessary) 
 
  
 YOU WILL BE GIVEN A COPY OF THIS CONSENT FORM TO KEEP. 
 
If you have any questions concerning this study or consent form beyond those answered by the 
investigator, including questions about the research, your rights as a research subject or research-
related injuries; or if you feel that you have been treated unfairly and would like to talk to someone 
other than a member of the research team, please feel free to contact the Medical Research Council of 


















Appendix 8: Interview guide for provider interviews 
 
1. Can you tell me about your job? What are your normal duties? 
- Routine activities 
- Special programmes 
- Interaction with staff and community 
2. What’s your role in PMTCT here? 
3. What’s the normal practice of PMTCT here? 
- How is knowledge imparted 
- How is HIV counselling and testing done 
- What drug regimens are used 
- Do patients pay for any of these services 
- Are guidelines available here 
- What staff cadres are involved in PMTCT 
- Is there any donor funding 
4. What is the situation concerning user fees for pregnant women attending ANC? 
- What services are paid for and which ones are free 
- What payment mechanisms are accepted 
- What amounts are charged and what are the changes ov r time 
- Exemptions: who is exempted and how do people access exemptions 
- What happens when people cant pay 
5. How has the use of services changed with the change in user fees? 
- Are there more or less women attending 
- What factors lead people to stay away 
- Where do they go instead 
- What has been done to ensure their safety in these other places 
6. Are there any problems in the management of HIV among pregnant women? 
7. Are there any difficulties you experience in the PMTCT program? 
- Do you have all the resources you need 
- Are there any areas that need improvement 
8. Do you believe women have any difficulties in accessing PMTCT services? 

















Appendix 9: Research Ethics Committee approval letter from the University of 
Cape Town 
UNIVERSITY OF CAPE TOWN , 
09 November 2009 
REC REF, 470/ 2009 
Ms FB Magaso 
Health Economics Units 
Dear Ms Magaw 
Health Sciences Faculty 
Research Ethics Committee 
Room E52-24 Groole Schuur Hospital Old Maio Building 
Observatory 7925 
l'elepbone [021] 4066626 • Facsimile [021J 406 6411 
e-mail: shuretta.thomas@Uct.ac.za 
PROJECT TITLE, ASSESSING THE BARRIERS TO ACCESSING PREVENTION OF 
MOTHER-TO-CHILD TRANSMISSION (PMTC'I) SE RVICES AMONG PREGNANT WOMEN 
IN MARONDERA, ZIMBABWE. 
Thank you for submitting your study to the Research E thics Committee. 
It is a pleasure to inform you that the Ethics Comm..ittcc has formally approved the above-mentioned study. 
Approval is granted for onc yeu till the 20m November 2010. 
Please submit an annual progress report if the research continues beyond the expiry date. Please submit a brief 
summary of findings if you complete the study within the approval period so that we can close our file. 
Please note that the ongoing ethical conduct of the srudy remains the responsibility of the principal 
investigator. 
Please quote the REC. REF in aU your correspondence. 
Yours sincerely 
~~ 
) (J PROFESSOR M BLOCKMAN 
{ J - CHAIRPERSON HSF HI !MAN ETHICS 
Federal Wide Assurance Number: FWAOOOO1637. 
Institutional Review Board (IRB) number.IRBOOOO1938 














Appendix 10: MRCZ ethical approval 
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C.UsewIY 
H.llIre 
MRCZ APPROVAL LETTER 
Ref: MRCZ/B/Il 
Ms. F. B. Magaso 
University or Cape Town 
Health Economics Unit 




Date: 14 December 200t 
RE: '!Wfinq !be ItDim To &grplng pn;yentlpn Of Hpther= To- g,11d TAnsmlglgn 
(PHTCO Smt\g::I Ampng pregnant Women In Httpndcp ZImbabwe 
Thank you for the above titled proposal that you 5tjbmitted to the Mediall Research Cooncil of u..babwe (MRCZ) 
for review. Please be adv!soed that the Medical Research Cound! of 21mbabwe has reviewed and IIII!mBIl your 
appialtlon to conduct the llbove titled studv. This Is based on the following: • 
(a) SWdy Protocol 
(b) consent Fomls (English And Shonal 
(el Survey QuestIooDalre 
• APPROVAl HUM8ER :MRCZ/B/81 
The aboYe details should be used (O:l aI WlespooidolCf:S, consent forms and documents as appn:ipIiate. 
• MRCZ MEETING DATE : H/A 
APPROVAL DATE 
• EXPIRATl0f4 DAn 
• TYPE OF MEETING 
: 14 o.c.mber, 2009 
: 13 December, 2(110 
: Expedited review 
After this date, this project may only continue upoII ~al. For IlUrpOSeS of renewal, a progress ~port on a stilrodart! 
fonn obtJinabIe from the MRC2 Offas should be sutmitted one month before the ~ date Cor continuing 
"""". 
S!RlOUS ADVERSE EVENT Rt:PORTlHG: .... S!Rlus problems hiMng to do wti'i!lllbjed safety must be reported In 
the Jnstltu\iOnaI Ethical f!eo.'ieN COmmittee (IERC) as wei as the MRC2 wilhin 3 worldng days IlSing stilndllrd forms 
obtainable rrom the I'RCZ 0I'IIces. 
MOOlflCATlOtIS: PrIor MRCZ and IERe approval using standard Ibrms CIll\lIirIabIe from the MRCZ 0fIices is ~~ 
Ilefon! impIeme.-rtlng any changes In the Protocol fitiduding dWiges II the oonsent doOJment:s). 
T!RMIHATlON OF SJ\JOY: On tI!mWIation of" studv. II report hM In be sub'nlt!l'!d to the MRCZ using standaId 
forms ~ rrom the Io'RC2 0I'I'0ces. 
QUESTIONS: F'IeMe oontact the MRCZ (O:l Telephooe No. (04) 791792, 791193 or by e-mail on 
mrg!!bmrglm'iharM m TW. 
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Appendix 11: Approval from provincial medical director of Mashonaland East 
30 November 2009 
Ms Farai Beverley Magaso 
University of Cape Town 
Faculty of Health Sciences 
School of Public Health and Family Medicine 













REo APPLICATION FOR APPROVAL TO CONDUCT RESF,ARCH. 
The above subject matter refers. 
Your application to conduct research on PMTCT in Mashonaland East province 
has been approved subject to production of a written approval by Medical 
Research C0L.f!tiI-o~-Zil:nb~pwe (MRCZ). 
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Appendix 12: Map of Marondera district 
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Appendix 13: Instructions for authors, BMC Health Services Research Journal 
Manuscript sections for Research articles  
 
Manuscripts for Research articles submitted to BMC Health Services Research should be 
divided into the following sections:  
Title page  
This should list the title of the article. The full names, institutional addresses, and e-mail 
addresses for all authors must be included on the title page. The corresponding author should 
also be indicated.  
Abstract  
 
The abstract of the manuscript should not exceed 350 words and must be structured into 
separate sections: Background, the context and purpose of the study; Methods, how the 
study was performed and statistical tests used; Results, the main findings; Conclusions, brief 
summary and potential implications. Please minimize the use of abbreviations and do not cite 
references in the abstract 
Background  
 
The background section should be written from the standpoint of researchers without 
specialist knowledge in that area and must clearly state - and, if helpful, illustrate - the 
background to the research and its aims. Reports of clinical research should, where 
appropriate, include a summary of a search of the literature to indicate why this study was 
necessary and what it aimed to contribute to the field. The section should end with a very 
brief statement of what is being reported in the article.  
Methods  
 
This should include the design of the study, the setting, the type of participants or materials 
involved, a clear description of all interventions and comparisons, and the type of analysis 
used, including a power calculation if appropriate.  
Results and Discussion  
 
The Results and Discussion may be combined into a single section or presented separately. 
Results of statistical analysis should include, where appropriate, relative and absolute risks or 
risk reductions, and confidence intervals. The results and discussion sections may also be 
broken into subsections with short, informative headings. 
Conclusions  
 
This should state clearly the main conclusions of the research and give a clear explanation of 
their importance and relevance. Summary illustrations may be included. 
















If abbreviations are used in the text, either they should be defined in the text where first used, 
or a list of abbreviations can be provided, which should precede the competing interests and 
authors' contributions.  
Competing interests  
 
A competing interest exists when your interpretation of data or presentation of information 
may be influenced by your personal or financial relationship with other people or 
organizations. Authors should disclose any financial competing interests but also any non-
financial competing interests that may cause them embarrassment were they to become public 
after the publication of the manuscript.  
Authors are required to complete a declaration of competing interests. All competing interests 
that are declared will be listed at the end of published articles. Where an author gives no 
competing interests, the listing will read 'The author(s) declare that they have no competing 
interests'.  
Authors' contributions  
 
In order to give appropriate credit to each author of a paper, the individual contributions of 
authors to the manuscript should be specified in this section. 
All contributors who do not meet the criteria for authorship should be listed in an 
acknowledgements section. Examples of those who might be acknowledged include a person 
who provided purely technical help, writing assistance, or a department chair who provided 
only general support. 
Authors' information  
 
You may choose to use this section to include any relevant information about the author(s) 
that may aid the reader‘s interpretation of the article, and understand the standpoint of the 
author(s). This may include details about the authors' qualifications, current positions they 
hold at institutions or societies, or any other relevant background information. Please refer to 
authors using their initials. Note this section should not be used to describe any competing 
interests.  
Acknowledgements and Funding  
 
Please acknowledge anyone who contributed towards the study by making substantial 
contributions to conception, design, acquisition of data, or analysis and interpretation of data, 
or who was involved in drafting the manuscript or revising it critically for important 
intellectual content, but who does not meet the criteria for authorship. Please also include 
their source(s) of funding. Please also acknowledge anyone who contributed materials 
essential for the study. 
Please list the source(s) of funding for the study, for each author, and for the manuscript 
preparation in the acknowledgements section. Authors must describe the role of the funding 















writing of the manuscript; and in the decision to submit the manuscript for publication.  
References  
 
All references must be numbered consecutively, in square brackets, in the order in which they 
are cited in the text, followed by any in tables or legends. Reference citations should not 
appear in titles or headings. Each reference must have an individual reference number. Please 
avoid excessive referencing. If automatic numbering systems are used, the reference numbers 
must be finalized and the bibliography must be fully formatted before submission.  
BMC Health Services Research reference style  
Style files are available for use with popular bibliographic management software: 
 BibTeX  
 EndNote style file  
 Reference Manager  
 Zotero  
Figure legends  
The legends should be included in the main manuscript text file rather than being a part of the 
figure file. For each figure, the following information should be provided: Figure number (in 
sequence, using Arabic numerals - i.e. Figure 1, 2, 3 etc); short title of figure (maximum 15 
words); detailed legend, up to 300 words.  
Please note that it is the responsibility of the author(s) to obtain permission from the 
copyright holder to reproduce figures or tables that have previously been published 
elsewhere.  
Preparing tables  
Each table should be numbered in sequence using Arabic numerals (i.e. Table 1, 2, 3 etc.). 
Tables should also have a title that summarizes the whole table, maximum 15 words. Detailed 
legends may then follow, but should be concise. 
Smaller tables considered to be integral to the manuscript can be pasted into the document 
text file. These will be typeset and displayed in the final published form of the article. Such 
tables should be formatted using the 'Table object' in a word processing program to ensure 
that columns of data are kept aligned when the file is sent electronically for review; this will 
not always be the case if columns are generated by simply using tabs to separate text.  
 
Larger datasets can be uploaded separately as additional files. Additional files will not be 
displayed in the final, published form of the article, but a link will be provided to the files as 
supplied by the author. 
Tabular data provided as additional files can be uploaded as an Excel spreadsheet (.xls) or 

















Style and language 
General  
 
Currently, BMC Health Services Research can only accept manuscripts written in English. 
Spelling should be US English or British English, but not a mixture.  
There is no explicit limit on the length of articles submitted, but authors are encouraged to be 
concise. There is no restriction on the number of figures, tables or additional files that can be 
included with each article online. Figures and tables should be sequentially referenced. 
Authors should include all relevant supporting data with each article.  
BMC Health Services Research will not edit submitted manuscripts for style or language; 
reviewers may advise rejection of a manuscript if it is compromised by grammatical errors. 
Authors are advised to write clearly and simply, and to have their article checked by 
colleagues before submission. In-house copyediting will be minimal. Non-native speakers of 
English may choose to make use of a copyediting service.  




Abbreviations should be used as sparingly as possible. They can be defined when first used or 
a list of abbreviations can be provided preceding the acknowledgements and references.  
 
Typography  
 Please use double line spacing. 
 Type the text unjustified, without hyphenating words at line breaks. 
 Use hard returns only to end headings and paragraphs, not to rearrange lines. 
 Capitalize only the first word, and proper nouns, in the title. 
 All pages should be numbered. 
 Use the BMC Health Services Research reference format.  
 Footnotes to text should not be used. 
 Greek and other special characters may be included. If you are unable to reproduce a 



















Appendix 14: Details of methods used 
1. Face-to-face interviews 
Data collection: 
These formulate the basis of the quantitative section of the study. Trained researchers 
conducted interviews averaging 30 minutes on each participant. A fully coded 
structured questionnaire was the basis of the face- to-face interview. The interviewer 
read out the questions to the participant and where answers were coded also read out 
the different responses. The participant then selected their response which the 
interviewer marked. Since the questionnaires were available in both Shona and 
English the participant was first asked which language they preferred before the 
interview process began. Having both Shona and English questionnaires minimised 
the risk of misinterpreting questions by the researcher or the participant. These 
interviews were conducted in a secluded quiet area to afford the women some privacy 
so as to enhance their confidence in the process. 
 
Limitations of method used: 
Like any other interview method, the main limitation of the method is the probability 
of the respondents giving answers that they think are expected of them. To minimise 
this bias, participants were informed of the confidentiality of the interview as well as 
the importance of their different views. 
 
Data reduction 
Responses on the questionnaires were already numerically coded so that the data was 
more comprehensible and manageable. 
 
Data analysis 
Coded data from the quantitative survey questionnaires was entered and cleaned using 
the Epi Info program immediately after completing the interviews. Both descriptive 
and analytic statistics were obtained from these data through use of the statistical 
software STATA© (Version 10). Analysis included univariate and multivariate 
regressions which were conducted to identify the relationships that existed between 
some variables and access to health services. 
 
To assess affordability of services, an analysis on the existence and/or extent of 
catastrophic health payments was conducted. If the health care expenses are large 
relative to the resources available to the household, this disruption to living standards 
is considered catastrophic (30). The idea is that spending a large fraction of the 
household budget on health care must be at the expense of the consumption of other 
goods and services. Whilst longitudinal data is normally used to estimate the extent to 
which living standards are seriously disrupted by the purchase of medical care, this 
was not possible to assess in the given cross-sectional study. A ratio of health 
payments-to-income was instead calculated in which payments were considered 















period (the full gestational period in this case) (31). Generally 5% to 10% of income 
is considered to be mild catastrophic expenditure whilst 15% to 40% are considered 
moderate to high.  
 
An index of socio-economic status (SES) was constructed through the Principal 
Components Analysis (PCA) technique using ownership of household assets (32). To 
avoid clumping and truncation (wereby households are grouped together in a small 
number of distinct clusters (clumping) or an even distribution of SES is spread over a 
narrow range making differentiating between socio-economic groups difficult 
(truncation)), several variables were used including housing characteristics such as 
roof material and wall material, access to utilities and infrastructure such as source of 
drinking water, energy and sanitation facilities, and durable asset ownership such as 
ownership of a car, truck or bicycle (32). Indices were constructed separately for rural 
and urban areas to avoid misrepresentation of wealth. For instance, ownership of a 
bicycle, livestock and a well in rural areas indicates wealth, yet the same assets do not 
have value in urban areas. Therefore to avoid making all rural dwellers appear less 
wealthy than urban dwellers, the indices were constructed separately.  
 
Knowledge about PMTCT was assessed through a short test included in the 
questionnaire. Where women answered the question correctly they were given one 
point. Where they answered incorrectly or were not sure they received no points. The 
result was then converted into a percentage for each participant. 
 
2. Semi-structured provider interviews 
Data collection: 
Trained researchers conducted semi-structured interviews with providers based on 
open-ended questions. Prior to the interviews being conducted the researchers had to 
go through the interview guide, go through the consent form and practice with a 
partner. These interviews were conducted in quiet secluded area to avoid disruptions 
and to enhance privacy. The researcher, guided by a loosely-structured short 
questionnaire, conducted the interview by posing open-ended questions to the health 
provider and listened to their response which was recorded on a digital audio tape, 
while noting any changes in body language. In the event  a new theme was introduced 
by the interviewee during the interview, some additional questions were asked in 
order to find out more information but all the questions on the questionnaire were 
addressed by the end of the interview. English was used during the interviews since 
both providers and researchers were well-versed with the language. 
 
Limitations: 
Again biases such as response bias were envisaged to surface although to a lesser 
extent since health providers were aware of the reasons for the study.  
 














The process of immersion/crystallisation as a method of data reduction and analysis 
was discussed in the protocol and manuscript sections 
3. Focus group discussions
Data collection:
These FGDs were conducted with pregnant women who had attended ANC and had
been notified by nurses about the potential to participate in the FGD. Two researchers
took part in each discussion, one moderating the discussion while the other was taking
notes and recording the discussion. The discussion was based on a loosely structured
interview guide which was not strictly adhered to but was rather used to keep the
discussion within certain confines.  The discussion was recorded on a digital audio
tape and complemented by notes taken during observation.  The discussion took place
in a room or outside the facility and non-participants including health providers were
not allowed in the vicinity. After each discussion the researchers met and expanded
the notes taken during the discussion.
Limitations:
While the FGD would stimulate debate and discussion among peers, the problem of
venturing off the topic or taking too long on one aspect of the discussion was 
envisaged to surface. As such the 2 researchers were tasked with facilitating the 
discussion and keeping it within confines so as to extract all the desired information.
Data reduction and analysis:
The process of immersion/crystallization was employed to reduce the data and 
analyse it. This was discussed in the protocol and manuscript. 
